The QualityStocks Daily Friday, December 6th, 2024

Today's Top 3 Investment Newsletters

Premium Stock Alerts(UPC) $3.3900 +222.86%

TechMediaWire(GXAI) $2.6000 +83.10%

360 Wall Street(SMX) $0.4900 +64.76%

The QualityStocks Daily Stock List

Coretec Group (CRTG)

StocksEarning, TaglichBrothers, StockEarnings and QualityStocks reported earlier on Coretec Group (CRTG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Coretec Group Inc. (OTCQB: CRTG) is a technology-based solutions firm that is focused on the development, testing and provision of different technologies, service solutions and products for energy-related industries.

The firm has its headquarters in Ann Arbor, Michigan and was incorporated in 1995, on August 11th. It operates as part of the communications equipment manufacturing industry. The firm has two companies in its corporate family and serves consumers in the United States.

The company’s innovative technology is based on CHS (cyclohexasilane Si6H12), a high value silicon precursor and the development of CSpace; a 3D volumetric display. The company was formed as a result of a merger between Coretec Industries LLC and 3DIcon Corporation.

The enterprise’s product portfolio is comprised of CHS, a liquid which converts to polysilane when it’s exposed to UV irradiation and heat, followed by amorphous silicon and crystalline silicon. It also develops a patented glasses-free 3D static volumetric display known as CSpace, which has been designed to produce high-resolution true 3D images with full color from 3D datasets transformed from raw datasets or datasets that have been generated by imaging systems, which can benefit from 3D visualization. The enterprise serves the international technology markets in security, environment, health, solar, semiconductor, electronics and energy.

Coretec Group (CRTG), closed Friday's trading session at $0.02265, up 33.5889%, on 4,914,100 volume. The average volume for the last 3 months is 409,956 and the stock's 52-week low/high is $0.0031/$0.0638.

SOL Global Investments Corp. (SOLCF)

QualityStocks, TradersPro and CFN Media Group reported earlier on SOL Global Investments Corp. (SOLCF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SOL Global Investments Corp. is a global investment company listed on the OTC Markets’ OTCQB. The Company centers on, but is not limited to, cannabis and cannabis related companies in legal U.S. States, the hemp and CBD (cannabidiol) marketplaces, and the developing European cannabis and hemp marketplaces. SOL Global Investments has its corporate headquarters in Toronto, Ontario. It also has offices in Fort Lauderdale, Florida, and London, England.

The Company has strategic investments and partnerships across cultivation, distribution and retail. These complement its research and development (R&D) program with the University of Miami. SOL Global is positioning the Company as a future frontrunner in the United States' medical cannabis industry.

SOL’s investments include ECH Ltd.; Verano Holdings LLC; OG DNA Genetics, Inc.; Greenlight Pharmaceuticals Limited; University of Miami; and PRØHBTD Media, Inc. ECH is a group of companies at the vanguard of the European medical cannabis industry. Verano Holdings is a private, vertically integrated, licensed operator of cannabis cultivation, manufacturing and retail facilities across six key U.S. States and Puerto Rico.

OG DNA Genetics is one of the foremost companies in the Cannabis Industry. Greenlight Pharmaceuticals Limited (GreenLight Medicines) is a biopharmaceutical company focused on researching, developing and licensing molecules from proprietary cannabinoid formulations to target a spectrum of disease areas.

SOL Global Investments Corp. (SOLCF), closed Friday's trading session at $0.2525, up 26.9482%, on 409,956 volume. The average volume for the last 3 months is 1,922,115 and the stock's 52-week low/high is $0.02/$0.2588.

Entero Therapeutics (ENTO)

We reported earlier on Entero Therapeutics (ENTO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Entero Therapeutics Inc. (NASDAQ: ENTO) is a clinical-stage biopharmaceutical firm focused on developing targeted and orally delivered therapies to help treat patients with a range of gastrointestinal illnesses.

The firm has its headquarters in Boca Raton, Florida and was incorporated in 2014. Prior to its name change in May 2024, the firm was known as First Wave BioPharma Inc. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe, with a focus on those in the United States.

The enterprise’s pipeline candidates include capeserod, a selective 5-HT4 receptor partial agonist under Phase 1 studies for the treatment of gastroparesis; and latiglutenase, a targeted oral biotherapeutic for celiac disease designed to breakdown gluten into non-immunogenic peptides, currently under Phase 2 studies. It is also involved in the development of niclosamide, an oral small molecule with anti-inflammatory inhibitor therapy, currently under Phase 2 studies for the treatment of ulcerative proctitis and ulcerative proctosigmoiditis, as well as immune checkpoint inhibitor-associated colitis and diarrhea in metastatic cancer patients. This is in addition to developing adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients, currently under Phase 2 studies for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis and chronic pancreatitis.

The company recently announced its entry into a binding letter of intent with Data Vault Holdings Inc. to exclusively license a pair of technology product suites owned by Data Vault; FotoDigm® and QOLPOM®. This strategic investment offers Entero access to both capital and technology for a pilot program and the initiation and potential improvement of the company’s future clinical trials. This may, in turn, encourage additional investments into the company.

Entero Therapeutics (ENTO), closed Friday's trading session at $0.7992, up 20%, on 1,922,115 volume. The average volume for the last 3 months is 7,181,317 and the stock's 52-week low/high is $0.185/$14.51.

Dermata Therapeutics (DRMA)

QualityStocks, Premium Stock Alerts, Tim Bohen, The Stock Dork, MarketBeat and InvestorsUnderground reported earlier on Dermata Therapeutics (DRMA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Dermata Therapeutics Inc. (NASDAQ: DRMA) is a clinical-stage biotechnology firm that is focused on treating aesthetic and medical skin conditions.

The firm has its headquarters in San Diego, California and was incorporated in December 2014 by Gerald T. Proehl and David F. Hale. The firm serves consumers around the globe.

The company believes it has the potential to address various facets of psoriasis vulgaris, acne rosacea, acne vulgaris and other multiple aesthetic areas with high unmet clinical needs. Its business strategy is to identify and develop innovative products that can be moved into clinical trials to demonstrate their safety and effectiveness in treating various indications.

The enterprise’s product portfolio is comprised of product candidates it has developed using its Spongilla platform technology. The technology is based on the use of Songillalacustris, a freshwater sponge which naturally grows in lakes and rivers in commercial quantities in different parts of the globe. The enterprise’s candidates include a once-a-week topical formulation dubbed DMT310, which is under clinical development and is indicated for the treatment of papulopustular rosacea, psoriasis vulgaris and acne vulgaris. It also develops a formulation dubbed DMT410, for the treatment of various aesthetic conditions like hyperhidrosis.

Dermata Therapeutics (DRMA), closed Friday's trading session at $1.44, up 19.0083%, on 7,181,317 volume. The average volume for the last 3 months is 33,951 and the stock's 52-week low/high is $1.0501/$13.35.

Gelteq Limited (GELS)

We reported earlier on Gelteq Limited (GELS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Gelteq Limited (NASDAQ: GELS) is a clinical and science-based firm focused on the formulation, development and commercialization of a gel-based delivery system for people and animals.

The firm has its headquarters in Caulfield, Australia and was incorporated in 2017. It operates as part of the drug manufacturers-specialty and generic industry, under the healthcare sector. The firm serves consumers around the globe.

The company’s gel-based delivery solutions preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally linked to other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is currently focused on expanding the application of its gel technology within the pharmaceutical, nutritional, pet and veterinary, and sports performance sectors.

Gelteq’s gel is a customizable platform for drug delivery that forms a chemically and physically stable matrix capable of holding multiple ingredients, including pharmaceuticals, nutraceuticals, and plant-based compounds. The gel’s composition and structure make it easier to consume for individuals who have difficulty swallowing medications, or generally suffer from dysphagia. In the body, the Gelteq drug delivery system enhances the therapeutic effectiveness of the compound delivered at every stage of ingestion, in both individuals and animals; from the moment of ingestion through to final absorption.

Gelteq Limited (GELS), closed Friday's trading session at $2, up 4.1612%, on 33,951 volume. The average volume for the last 3 months is 18,821,002 and the stock's 52-week low/high is $1.42/$4.9799.

Microsoft Corp. (MSFT)

The Street, InvestorPlace, Kiplinger Today, Zacks, The Online Investor, Daily Trade Alert, StockMarketWatch, Schaeffer's, StreetInsider, MarketClub Analysis, StreetAuthority Daily, Money Morning, Investopedia, TopStockAnalysts, Trades Of The Day, IT News Daily, QualityStocks, InvestorGuide, NetworkNewsWire, Stocks to Buy Now, SeriousTraders, SmallCapRelations, Early Bird, Market Intelligence Center Alert, internetnews, MarketBeat, PROFIT CONFIDENTIAL, Top Pros' Top Picks, The Motley Fool, Daily Wealth, Uncommon Wisdom, internet, Louis Navellier, Wealth Insider Alert, Cabot Wealth, Daily Market Beat, Flagler Financial Group, ProfitableTrading, Investor Guide, Street Insider, The Wealth Report, Barchart, INO Market Report, The Street Report, CNBC Breaking News, Wyatt Investment Research, StocksEarning, Dividend Opportunities, SiliconValley, SmarTrend Newsletters, Daily Profit, StrategicTechInvestor, MarketWatch, Insider Wealth Alert, Money and Markets, GorillaTrades, Investors Alley, TipRanks, CustomerService, Stansberry Research, iStockAnalyst, FreeRealTime, Wealth Daily, INO.com Market Report, TradingAuthority Daily, Trading Markets, The Growth Stock Wire, TheStockAdvisors, Investment U, WStreet Market Commentary, Marketbeat.com, Total Wealth, Investing Daily, Willy Wizard, Greenbackers, Wall Street Daily, Energy and Capital, AllPennyStocks, DividendStocks, Contrarian Outlook, TheStockAdvisor, Money Wealth Matters, Daily Markets, Eagle Financial Publications, Market Intelligence Center, Trade of the Week, Investiv, SmallCap Network, Penny Stock Buzz, StockEarnings, Shah's Insights & Indictments, Dynamic Wealth Report, Darwin Investing Network, The Daily Market Alert, Trader Prep, Market Authority, FeedBlitz, Forbes, Power Profit Trades, The Night Owl, FNNO Newsletters, Wall Street Elite, Investor Update, SmallCapVoice, Daily Dividends, Stockhouse, TradingMarkets, BullDogReporter, TraderPower, Short Term Wealth, MarketMovingTrends, Trading Concepts, StockTwits, Inside Investing Daily, Jon Markman’s Pivotal Point, Stock Up Featured, Coattail Investor, Options Elite, Bourbon and Bayonets, PennyOmega, The Trading Report, Investing Futures, Investing Lab, InvestorsObserver Team, CRWEFinance, Investment House, Wall Street Greek, InvestmentHouse, The Best Newsletters, Super Stock Investor, The Weekly Options Trader, MarketArmor.com, TheOptionSpecialist, ChartAdvisor, DrStockPick, 24/7 Trader, Momentum Traders, Traders For Cash Flow, InsiderTrades, Momentum Trades, SmallCapNetwork, Stocks To Watch, The Stock Dork, YOLOTraderAlerts, PennyToBuck, TradeSmith Daily, CRWEWallStreet, BestOtc, Market Pulse, equities Canada, Stock Gumshoe, Early Investing, StreetAlerts, wyatt research newsletter, Weekly Wizards, Leeb's Market Forecast, Agora Financial and InvestorIntel reported earlier on Microsoft Corp. (MSFT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

IBM, an American multinational technology firm and Janes, a defense intelligence firm, are collaborating to bridge the gap between trustworthy artificial intelligence and defense operations.

By pairing artificial intelligence with high-quality data, the companies hope to usher in a new era of defense operations that’ll enable commanders to make better informed decisions based on AI-generated data in real time. This partnership will see the companies integrate open-source security and defense intelligence data into watsonx, a trusted artificial intelligence and data platform.

In detail, the firms will integrate the watsonx AI with a retrieval-augmented generation pattern containing Janes data. This pattern can assist intelligence and military analysts by generating data-augmented reports for decision making and situational analysis while also offering operational decision support.

This will lay the groundwork that’ll allow defense leaders to access high-quality data merged with trustworthy artificial intelligence to improve their decision advantage. Trustworthy artificial intelligence refers to artificial intelligence systems that are fair, secure, safe, strong, interpretable and explainable. These qualities instill confidence and trust in these systems among end users as well as stakeholders.

Retrieval-augmented data analysis and AI-assisted scenario modelling will also help defense teams mitigate risks and anticipate any issues that may arise, in addition to enabling more informed mission planning.

The opportunities offered by trustworthy AI for national defense and security organizations are plenty and often vary from one country to another. Allowing defense leaders to access Janes’ open-source security and defense intelligence data on the watsonx AI platform will support the trustworthy, secure and safe use and development of artificial intelligence from bases of operations to the battlefield.

Through the partnership, defense leaders will also be able to work together with allies across countries, agencies and departments to improve national security with strong governance, bolster operational readiness, and hasten decision-making.

IBM is the leading firm when it comes to developing responsible artificial intelligence solutions using its watsonx AI platform. The watsonx AI and data platform comprises of 3 core components and AI assistants that have been designed to help parties accelerate and scale the impact of artificial intelligence using one’s data across their business.

Its solutions include watsonx.governance, which assists organizations in adopting artificial intelligence in an innovative, responsible and safe way. This solution also enhances compliance while mitigating any AI risks that may arise.

Overall, the partnership with Janes is expected to supplement human decision-making in national defense and security organizations in a responsible way.

As more companies like Microsoft Corp. (NASDAQ: MSFT) bring onto the market their different AI solutions, the defense sector is likely to witness major transformations as these AI innovations make their way into different aspects of operations.

Microsoft Corp. (MSFT), closed Friday's trading session at $443.57, up 0.2146311%, on 18,821,002 volume. The average volume for the last 3 months is 26,206,157 and the stock's 52-week low/high is $364.13/$468.35.

MicroStrategy Inc. (MSTR)

Schaeffer's, InvestorPlace, Zacks, StocksEarning, StockEarnings, Kiplinger Today, The Street, MarketBeat, Early Bird, TradersPro, StreetInsider, SmarTrend Newsletters, FreeRealTime, MarketClub Analysis, Uncommon Wisdom, QualityStocks, Investors Alley, Cabot Wealth, Investopedia, Premium Stock Alerts, StreetAuthority Daily, Money Morning, Barchart, CNBC Breaking News, Investors Underground, Daily Trade Alert, Top Pros' Top Picks, Wealth Insider Alert, Inside Trading, BUYINS.NET, DividendStocks, Dynamic Wealth Report, Eagle Financial Publications, Earnings360, SmartMoneyTrading, INO.com Market Report, InsiderTrades, internetnews, Jeff Bishop, Smart Investing Society, The Online Investor, AllPennyStocks, TradeSmith Daily, Trading Concepts, Marketbeat.com and Greenbackers reported earlier on MicroStrategy Inc. (MSTR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Bitcoin price is nearing a historic $100,000, propelled by a remarkable rally following the U.S. elections. This has sparked interest in identifying promising investment opportunities in the crypto space for 2025. According to Mark Plamer, an analyst at Benchmark, Galaxy Digital and MicroStrategy Inc. (NASDAQ: MSTR) are two long-standing favorites among cryptocurrency fans.

Palmer estimates MicroStrategy’s fair value at $650, representing a potential 68% increase from its current price. For Galaxy Digital, he projects at least a 16% rise, targeting $29 based on his analysis.

MicroStrategy, initially established as a software firm by Michael Saylor, has evolved into a crypto-focused entity. Saylor, whose net worth is estimated at $9.6 billion, has aggressively invested in Bitcoin, cementing his reputation as a devoted supporter of the digital asset.

While MicroStrategy’s software division remains strong, its financial contribution to the company is minimal in the context of its overall valuation. According to Palmer, the software segment accounts for just $2 of the $650 target price. He explained that while there are some operational synergies, the software business has limited significance in determining the company’s stock value.

Saylor’s bold strategy of acquiring and retaining Bitcoin reserves has generated significant attention. Palmer likened it to a hypothetical scenario where the CEO of a major retailer began stockpiling Tesla vehicles for their batteries. Although unconventional, Saylor’s moves bear similarities to how oil companies are valued based on their reserves and the potential to utilize those assets in the future.

Palmer elaborated that the metric known as Bitcoin yield—calculated by dividing the number of bitcoins purchased during a specific period by the company’s total diluted shares—offers insight into the additional value generated by MicroStrategy’s treasury operations.

For example, recent filings with the SEC revealed that between November 18 and November 24, the company spent $5.4 billion acquiring 55,000 bitcoins at an average price of $97,862 each. This brings its total Bitcoin holdings to approximately 386,700, purchased at a cumulative cost of $21.9 billion, averaging $56,761 each.

Turning to Galaxy Digital, its CEO and founder Mike Novogratz has drawn on his experience at Goldman Sachs to create a crypto-focused firm with a capital markets approach. The company facilitates trading and lending, positioning itself as a sophisticated option for institutional investors venturing into crypto.

Palmer noted that as institutional interest in cryptocurrency grows, Galaxy Digital is well-placed to capitalize on this trend. The firm has also gained traction among those exploring AI, thanks to its expansion of the Helios data center in West Texas.

MicroStrategy Inc. (MSTR), closed Friday's trading session at $395.01, up 2.2283%, on 26,206,157 volume. The average volume for the last 3 months is 21,462,393 and the stock's 52-week low/high is $43.874/$543.00.

Alphabet Inc. (GOOGL)

The Street, InvestorPlace, Kiplinger Today, Zacks, The Online Investor, Schaeffer's, Daily Trade Alert, Investopedia, Trades Of The Day, Market Intelligence Center Alert, Money Morning, Early Bird, MarketBeat, MarketClub Analysis, StreetInsider, Uncommon Wisdom, StreetAuthority Daily, Top Pros' Top Picks, Wealth Insider Alert, Daily Profit, StrategicTechInvestor, The Street Report, Wyatt Investment Research, Wall Street Daily, The Wealth Report, Money and Markets, TopStockAnalysts, CustomerService, Louis Navellier, AllPennyStocks, MarketWatch, StocksEarning, All about trends, QualityStocks, Investing Daily, TipRanks, Daily Wealth, ProfitableTrading, INO.com Market Report, CNBC Breaking News, Stansberry Research, Investors Alley, Marketbeat.com, INO Market Report, MarketArmor.com, MarketTamer, Market Intelligence Center, Darwin Investing Network, Trading Tips, Power Profit Trades, Stock Up Featured, InsiderTrades, InvestorGuide, Barchart, Options Elite, InvestorIntel, StockEarnings, DividendStocks, Cabot Wealth, Total Wealth, Money Wealth Matters, GorillaTrades, TheOptionSpecialist, The Night Owl, SmallCapNetwork, Daily Dividends, The Daily Market Alert, Jon Markman’s Pivotal Point, Insider Wealth Alert, FreeRealTime, Dynamic Wealth Report, WStreet Market Commentary, Investiv, Short Term Wealth, Investing Futures, Trader Prep, The Motley Fool, Investor Guide, Investing Signal, The Weekly Options Trader, Eagle Financial Publications, SmallCap Network, InvestorsObserver Team, 24/7 Trader, Trade of the Week, Market Authority, Smartmoneytrading, Average Joe Options, TradingPub, StockMarketWatch, Chaikin PowerFeed, Trading Concepts, Investing Lab, TradeSmith Daily, Investment House, StockReport, Wealth Daily, Equities.com, Contrarian Outlook, Jim Cramer, Shah's Insights & Indictments, The Wall Street Transcript, Stock Barometer, Investing Breakout, Inside Investing Daily, Traders For Cash Flow, Lance Ippolito, Pennystockmania, Investment U, Mind Over Markets, Tradespoon, Financials Trends, Profit Confidential, TrendAdvisor, RedChip, CNBC, ChartAdvisor, BUYINS.NET, Schaeffer’s, Earnings360 Newsletter, The Stock Dork, Top Pros Top Picks, The Trading Report, Investor News, Liberty Through Wealth, Tim Bohen, Jeff Bishop, Day Trade Alert, IT News Daily, Candle Stick Forum, Profits Run, SystemTrading, Stock Gumshoe, iStockAnalyst, Smart Investing Today, SwingTradeOnline, Rockwell Trading, Prism MarketView, Roundtable Roundup, Jon Markman's Pivotal Point, bullseyeoptiontrading, BillionDollarClub, Beat The Street, Tim Sykes, Summa Money, SECFilings.com News, wyatt research newsletter, 360 Wall Street, Kiplinger’s Weekly Update, Chart Experts, Goldman Small Cap Research, Technology Profits Daily, SmallCapVoice, 1 2 3 Trade Option, SmartTrading, Navellier Growth, Inside Trading, MarketMovingTrends and OilAndEnergyInvestor reported earlier on Alphabet Inc. (GOOGL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Alphabet’s (NASDAQ: GOOGL, GOOG) Waymo is set to expand its autonomous ride-hailing services to Miami, Florida, as part of its strategic growth plan. The company plans to introduce its vehicles to Miami’s streets early next year, with a full launch to riders anticipated in 2026 through the Waymo One app. This move is part of Waymo’s efforts to gain a competitive edge in the autonomous vehicle market, which includes strong competitors like General Motors’ Cruise, Amazon’s Zoox, and Tesla.

Waymo’s expansion into Miami comes at a time when the company is under scrutiny from safety regulators due to incidents involving autonomous driving technology. Miami will join other cities like Phoenix, Los Angeles, San Francisco, and Austin where Waymo already operates. Waymo has partnered with vehicle financing firm Moove to manage its fleet operations, facilities and charging infrastructure, starting in Phoenix, Arizona. This partnership is crucial for supporting Waymo’s growth and ensuring efficient operations.

Alphabet Inc. supports Waymo’s expansion with a strong financial foundation. The company has a price-to-earnings (“P/E”) ratio of approximately 22.74 indicating investor confidence in its earnings potential. Alphabet’s price-to-sales ratio stands at about 6.31 while its enterprise value to sales ratio is roughly 6.33, reflecting its market valuation relative to revenue.

Alphabet’s enterprise value to operating cash flow ratio is around 20.47, showing the company’s ability to generate cash from operations. The earnings yield for Alphabet is approximately 4.40%, providing a measure of the return on investment for shareholders. Additionally, Alphabet maintains a debt-to-equity ratio of about 0.035, indicating low leverage and a strong financial position.

The current ratio of approximately 1.95 suggests that Alphabet has a strong liquidity position, ensuring it can meet its short-term obligations. This financial stability supports Waymo’s expansion efforts, allowing the company to invest in new markets like Miami and continue its growth in the competitive autonomous vehicle industry.

To view the company’s latest earnings release, visit https://ibn.fm/1vFFk

About Alphabet Inc.

Alphabet is a collection of companies, the largest of which is Google. Larry Page and Sergey Brin founded Google in September 1998 and the company is headquartered in Mountain View, California. Billions of people use its wide range of popular products and platforms each day, like Search, Ads, Chrome, Cloud, YouTube and Android. For more information, visit the company’s website at www.ABC.xyz.

Alphabet Inc. (GOOGL), closed Friday's trading session at $174.71, up 1.199%, on 21,462,393 volume. The average volume for the last 3 months is 46,944,506 and the stock's 52-week low/high is $129.685/$191.75.

Rivian Automotive Inc. (RIVN)

Schaeffer's, InvestorPlace, QualityStocks, The Street, Kiplinger Today, MarketBeat, MarketClub Analysis, Early Bird, StockEarnings, INO Market Report, Investopedia, The Online Investor, GreenCarStocks, Zacks, AllPennyStocks, Daily Trade Alert, TipRanks, FreeRealTime, BillionDollarClub, Louis Navellier, StocksEarning, The Night Owl, Trades Of The Day, DividendStocks, InvestorsUnderground, InvestorIntel, 360 Wall Street, Premium Stock Alerts, Cabot Wealth, Chaikin PowerFeed, Premium Stock Picks, Top Pros’ Top Picks, Top Pros' Top Picks, bullseyeoptiontrading, Jeff Bishop, Rick Saddler, Hit and Run Candle Sticks, InsiderTrades, Investors Underground and StockReport reported earlier on Rivian Automotive Inc. (RIVN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Rivian Automotive Inc. (NASDAQ: RIVN), an electric vehicle (EV) manufacturer, is taking a fresh approach to car controls. Instead of the boring and plain designs many cars use, Rivian has created something fun, colorful, and inspired by anime and optimism. This new design makes interacting with the car more enjoyable and reflects Rivian’s vision for a better, more sustainable future.

Jeff Hammoud, Rivian’s Chief Design Officer, explains that the goal behind the redesign was to bring “optimism” into the driving experience. Unlike the aggressive and harsh designs often seen in trucks, Rivian wanted their vehicles to feel welcoming and friendly. Hammoud says their vehicles and software reflect a belief in protecting the planet for future generations.

The new software design matches Rivian’s brand, which focuses on positivity and hope. The cheerful look of the car’s interface is meant to make drivers feel good every time they use it.

The updated software from Rivian makes use of graphics inspired by Japanese anime and Studio Ghibli films. These animations are colorful, dynamic, and playful so that when you change a driving mode, the screen doesn’t just show a boring menu—it transforms.

For example, switching to “Snow Mode” displays a beautiful snowy landscape, while “Sport Mode” creates a racing scene with glowing lights and speed lines. This makes adjusting the car’s settings not only functional but also entertaining. Rivian has even added “costumes” to the software, inspired by classic movies and TV shows like Back to the Future and Knight Rider.

Rivian used Unreal Engine, a powerful 3D graphics tool popular in video games, to create these visuals. This technology makes it easy to customize the graphics for each vehicle. For instance, the screen will show your car’s exact color and wheel type, creating a more personal experience.

Hammoud explained that this technology saves time and effort. Instead of drawing thousands of images for different car options, the software generates them instantly.

While these animated graphics may not be necessary for driving, they add a unique personality to Rivian’s vehicles. The design makes using the car’s controls something drivers can look forward to, rather than just a task.

The interface also represents a step forward in how we interact with modern vehicles. Rivian’s software shows how EV makers can combine technology and art to create a better driving experience.

As Rivian continues to update its cars, the company plans to keep improving its software and adding new features. With this mix of optimism, anime inspiration and innovation, Rivian is setting a new standard for EV design.

Rivian Automotive Inc. (RIVN), closed Friday's trading session at $13, up 5.3485%, on 46,944,506 volume. The average volume for the last 3 months is 165,565 and the stock's 52-week low/high is $8.26/$24.615.

Innovative Industrial Properties Inc. (IIPR)

InvestorPlace, QualityStocks, Kiplinger Today, The Online Investor, Top Pros' Top Picks, Schaeffer's, Daily Trade Alert, MarketBeat, The Street, DividendStocks, Wealth Insider Alert, Trades Of The Day, The Wealth Report, Zacks, CannabisNewsWire, TradersPro, FreeRealTime, StreetInsider, Stock Up Featured, StockMarketWatch, The Street Report, Investopedia, Trading Concepts, Early Bird, CFN Media Group, Stock Gumshoe, Outsider Club, Marketbeat.com, StreetAuthority Daily, TipRanks, Inside Trading, VectorVest and Wealth Daily reported earlier on Innovative Industrial Properties Inc. (IIPR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Marijuana farmers in the state of California revealed that the weather during this year’s growing season was favorable, which may improve yields and in turn, prices.

Judi Nelson, co-founder of Sol Spirit Farm, revealed that the summer was good for them, noting that moisture from spring rain prevented wildfires. The overall threat of wildfires was low this year for cannabis farmers, which allowed them to focus on their crops more. In the last couple of years, these fires have greatly impacted farmers, with some experiencing extensive crop loss.

Flower from Sol Spirit is primarily sold in the firm’s compostable packaging, which Nelson reveals tells their story. The farm’s plants are certified regenerative, which permits the firm to price its flower higher than other brands.

There are tiers to sun-grown cannabis products; top shelf, mids and mass-produced. Most of the products that come from California’s Emerald Triangle are top shelf.

Sol Spirit flower is priced almost 3.5 times more than mass-produced flower because of the time the firm puts into its product as well as product quality. Marijuana cultivated in the sun is said to have an earthy aromas and rich terpene profiles, which enthusiasts note are more natural in comparison to strains cultivated indoors.

Nelson believes that prices for craft flower will increase especially as some players exit the market, noting that consumers want high quality flower that’s not been exposed to any impurities.

Nya Hessler of Amaranth Farms expects that despite an abundance of craft marijuana flower in the market, product will be going for roughly $500 per pound. While this is good, taxes for sun grown marijuana remain high.

Ironside Gardens owner Peter Maric has proposed that excise tax for all sun grown products be reduced to 5-7%. This comes after an announcement was made that marijuana excise taxes would increase to 19% from 15% in 2025.

Following the pesticide scandal that occurred earlier in the year, demand for sun-grown marijuana is also expected to increase. To prevent lower demand from consumers, some brands have eliminated the use of organic pesticides in their operations. Autumn Brands, based in Carpinteria, is one of these brands. The firm has fully transitioned to an all-natural marijuana pest management system that uses ladybugs native to the state.

This comes after it also threw away thousands upon thousands of cannabis plants that had been sprayed with organic pesticides after research demonstrated that these chemicals were harmful when heated.

Industry actors and allied players like Innovative Industrial Properties Inc. (NYSE: IIPR) are glad that there is some good news coming out regarding the cannabis industry in California since several challenges, such as high taxes, have been weighing down licensed players in that jurisdiction.

Innovative Industrial Properties Inc. (IIPR), closed Friday's trading session at $106.68, off by 0.7166124%, on 165,565 volume. The average volume for the last 3 months is 514,470 and the stock's 52-week low/high is $84.61/$138.35.

Cresco Labs Inc. (CRLBF)

QualityStocks, InvestorPlace, Kiplinger Today, Daily Trade Alert, MarketBeat, Cabot Wealth, CannabisNewsWire, Top Pros' Top Picks, The Street, The Wealth Report, Wealth Insider Alert, Trading For Keeps, Trades Of The Day, The Online Investor, Early Bird, Prism MarketView, StreetInsider, wyatt research newsletter, TradersPro and StocksEarning reported earlier on Cresco Labs Inc. (CRLBF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A recent study examining the use of prescribed opioids in Utah after medical cannabis legalization in the state highlights a significant reduction in opioid consumption among patients managing chronic pain. The findings also show a substantial decline in opioid prescription-related deaths since Utah authorized medical marijuana in 2018.

The study highlights the increasing use of cannabis for pain relief and its potential to lessen opiate dependence. It concludes that cannabis could be a promising option as healthcare providers explore safer methods for managing pain, especially for individuals with chronic pain conditions.

The Utah study analyzed 186 chronic pain patients, using data from medical cannabis dispensary transactions and corresponding medical records. The information was de-identified and processed using a HIPAA-compliant system developed by MSA.

The participant group included slightly more females (54%) than males (45%), with the majority (87%) being white. Ages ranged between 23 and 89 years, with an average age of 49. Nearly all participants (98.9%) resided in Utah, while a small portion came from New Mexico and Oregon.

The patients in the study experienced various types of chronic pain. Over half (57%) suffered from musculoskeletal pain, while others dealt with visceral pain (19%), orofacial pain and headache (13%), primary pain (4%), neuropathic pain (3%), and postsurgical or post-traumatic pain (2%).

More than 84% of participants decreased their morphine milligram equivalents (MME), a measure of opioid use. In particular, there was a 53.1% average reduction. Before starting on medical marijuana, the mean opioid use was 3,832 MME per month, which fell to 1,798 MME per month after beginning cannabis treatment.

Patients with musculoskeletal pain accounted for the majority of those who reduced opioid use, while individuals with neuropathic pain experienced the most significant reductions.

Interestingly, the study found that patients with orofacial pain or chronic headaches showed a 20.6% increase in opioid use, while other conditions saw reductions ranging from 10.9% to 73.5%. Additionally, individuals who smoked tobacco before using cannabis reported higher opioid use after starting cannabis treatment. This suggests that specific conditions and behaviors may influence the effectiveness of marijuana as a substitute for opioids.

While the findings show promising results linking medical cannabis to fewer overdose deaths and lower opioid use in Utah, the researchers stressed the need for further investigation. They recommend larger and more diverse studies to validate the findings and improve marijuana-based treatment regimens. They also recommended future research to explore optimal cannabinoid dosages and their effects on different populations.

As more of these studies are undertaken and published, the full extent to which medical cannabis products from various licensed companies like Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) are helping patients will gradually be documented.

Cresco Labs Inc. (CRLBF), closed Friday's trading session at $1.0755, off by 1.6011%, on 514,470 volume. The average volume for the last 3 months is 316,914 and the stock's 52-week low/high is $1.0176/$2.65.

Damon Inc. (DMN)

We reported earlier on Damon Inc. (DMN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Damon (NASDAQ: DMN), a maker of high-tech, high-performance motorcycles, announced key leadership changes to enhance operational efficiency and production capabilities. Co-founder Dominique (Dom) Kwong has been appointed interim CEO, succeeding Jay Giraud, while Shashi Tripathi, a seasoned executive with expertise in scaling companies, has been named Chairman of the Board. Kwong, with 25 years of experience in consumer and automotive technology, played a pivotal role in developing Damon's patented CoPilot and SHIFT technologies. Tripathi, founder of Nurture Growth Fund and current CEO of Sleepiz USA, brings a proven track record in regulated industries and operational management. The leadership team aims to focus on disciplined pre-production management and systematic operational improvements to advance Damon’s innovative approach to electric motorcycles and deliver stakeholder value.

To view the full press release, visit https://ibn.fm/eru5B

About Damon Inc.

Damon is on a mission to cause a paradigm shift for safer, smarter motorcycling. With its development offices in San Rafael, California , Damon is led by entrepreneurs and executives from world-class EV and technology companies.  Anchored by the groundbreaking HyperDrive™ electric powertrain, all Damon motorcycles are set to deliver power and range that exceeds that of gas without the noise, emissions, or maintenance hassles. Damon has captured the attention of the motorcycling world cutting edge designs and innovative safety technologies including CoPilot™ and Shift™, which are attracting a new generation of motorcycle riders. With strong consumer interest in the US and abroad, Damon aims to set the standard for motorcycle safety and sustainability worldwide. For more information, please visit damon.com.

For more information, visit the company’s website at https://damon.com/

Damon Inc. (DMN), closed Friday's trading session at $0.88, off by 3.6145%, on 316,914 volume. The average volume for the last 3 months is 12,712 and the stock's 52-week low/high is $0.7632/$4.95.

The QualityStocks Company Corner

SOBRsafe Inc. (NASDAQ: SOBR)

The QualityStocks Daily Newsletter would like to spotlightFathom SOBRsafe Inc. (NASDAQ: SOBR).

SOBR Safe (NASDAQ: SOBR) ("SOBRsafe"), a provider of next-generation transdermal alcohol detection technology, recently announced the launch of its fully integrated enterprise software solution that is expected to transform how health providers monitor and manage alcohol compliance. "To complement its software solution for point-of-care screening SOBRcheck(TM) and continuous monitoring SOBRsure(TM), this enterprise software is designed to enhance responsiveness to treatment, reduce recidivism and drive positive patient outcomes," reads an article discussing the launch.

"We created the SOBRsafe enterprise software to address the significant challenges experienced by behavioral health centers and providers across the country," said David Gandini, SOBRsafe's CEO. "By integrating our technologies into an effective and user-friendly dashboard, we equip users with powerful monitoring tools to drive positive outcomes while significantly impacting organizational efficiency."

To view the full article, visit https://ibn.fm/kJ4MK

SOBRsafe Inc. (NASDAQ: SOBR) is a provider of a game-changing transdermal (touch-based) alcohol detection technology that can improve workplace safety and provides advanced screening and monitoring solutions for the behavioral health industry.

Alcohol misuse is the fourth leading cause of preventable death in the U.S., and the seventh worldwide. Nearly half of all industrial accidents with injuries are alcohol-related, and 1-in-10 U.S. commercial drivers tests positive for alcohol – the highest rate in the world. Despite these statistics, prevention and monitoring solutions have not kept pace with this epidemic. Legacy detection technologies are invasive and inefficient, unhygienic and unconnected. SOBRsafe believes there is a better way.

The company has developed a patent-pending alcohol detection device called SOBRcheck™ for use in detecting alcohol in humans, with just the touch of a finger. SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol as emitted through a user’s skin. No breath, blood or urine sample is required. SOBRsafe believes its technology is a superior, hygienic alternative to traditional breathalyzers for frontline, preventative applications.

With a powerful backend data platform, SOBRsafe provides humane, passive and connected alcohol detection for the behavioral health, transportation, oil and gas, judicial and consumer markets.

A preventative solution in historically reactive industries, SOBRsafe technology is being deployed for commercial fleets, workplaces, alcohol rehabilitation, probation management and teen drivers. This monitoring technology helps prevent intoxicated workers from taking the factory floor or drivers from receiving the keys to a truck, bus or family car. An offender is immediately flagged, and an administrator is empowered to take the appropriate corrective actions.

SOBRsafe technology is commercially available for access control (SOBRcheck), wearable use (SOBRsure™) and licensing or white labeling.

The company is headquartered in the Denver (CO) Technology Center.

Products

The SOBRsafe technology is integrated within the company’s robust and scalable data platform, producing statistical and measurable user and business data.

SOBRsafe™

With a mission is to save lives, increase productivity, create significant economic benefits and positively impact behavior, SOBRsafe developed the scalable, patent-pending SOBRsafe™ platform for non-invasive alcohol detection, real-time reporting and historical data aggregation.

SOBRsafe is a solution that has broad applications in behavioral health, fleet and facility safety, youth drivers and judicial markets.

SOBRcheck™

SOBRcheck is the company’s stationary identification and alcohol monitoring product, providing a quick, specific-point-in-time test for the presence of alcohol. In hygienic, real-time fashion, SOBRcheck verifies user identity and determines the absence or presence of alcohol.

SOBRcheck provides an administrator immediate results – delivered securely – to aid in the efficient management of an existing substance abuse policy.

SOBRsure™

SOBRsure is the company’s transdermal, alcohol-detecting wearable. SOBRsure provides continuous, mobile alcohol monitoring. The band’s advanced alcohol safety technology discreetly detects and instantaneously reports the presence of alcohol in the body. Additionally, SOBRsure provides app-based alcohol detection alerts, pinpoint location tracking and band-removal notifications.

The SOBRcheck and SOBRsure revenue models consist of two components: (1) a hardware device purchase and (2) a recurring monthly SaaS subscription fee.

Design, manufacturing, quality testing and distribution for all SOBRsafe devices takes place in the U.S.

 

Market Opportunity

A report from Data Bridge Market Research, an international market research and consulting firm, estimated the global alcohol sensor market at $2.3 billion in 2022. The market is forecast to reach a value of $6.3 billion by 2030, recording a CAGR of 13.7% over the forecast period.

Market growth drivers, as cited by the report, include rising alcohol consumption rates, more stringent laws pertaining to alcohol consumption and new, more effective technologies that facilitate detection and enforcement.

Greater awareness of alcohol consumption as a potential threat to public and workplace safety has led to increased emphasis on preventing operation of motor vehicles and machinery by those under the influence of alcohol and promoting responsible alcohol consumption, as the report details.

Management Team

David Gandini is Chairman and CEO of SOBRsafe. He most recently served as president of IPS Denver, a bank card personalization company. Prior to that, Dave was the COO at First World Communications, a U.S. internet and data center provider, and participated in its successful IPO. He previously founded Pace Network Services and facilitated a successful exit to ICG Communications. Dave also co-founded Detroit-based Digital Signal in the fiber optic long haul market sector, where he executed a successful exit to SP Telecom.

Chris Whitaker, CPA, is CFO of SOBRsafe. Previously, Chris had served as the Company’s Vice President of Finance and Accounting. He has held various executive finance positions with large public multi-national corporations and small entrepreneurial companies throughout a progressive 30-year career that began with KPMG. Chris was formerly President – Americas and Vice President of Finance and Administration for public, multinational corporation Elixinol. He also served as the Managing Director of AEGIS Financial Consulting, leading a team of consultants in providing fractional CFO and financial consulting services to a wide variety of businesses in the public and private sectors.

Scott Bennett is EVP, Business Operations at SOBRsafe. He has more than 20 years of experience as a senior executive in technology-driven enterprises. Prior to joining SOBRsafe, he co-founded cybersecurity firm GBprotect and served as its COO until its successful sale to Nuspire. He previously served as Chief Technical Officer/Chief Information Security Officer of fintech businesses Catalyst Card Company and Integrated Printing Solutions.

SOBRsafe Inc. (NASDAQ: SOBR), closed Friday's trading session at $5.04, up 0.1988072%, on 12,712 volume. The average volume for the last 3 months is 4,163 and the stock's 52-week low/high is $3.70/$87.945.

Recent News

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)

The QualityStocks Daily Newsletter would like to spotlight Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI).

Parvovirus B19, often referred to as the B19 virus, is a seasonal respiratory viral illness that is transmitted through respiratory secretions from an infected individual's sneezes or coughs, their blood or blood products, or through vertical transmission from a pregnant woman to her baby. Common symptoms include joint pain in adults and slapped cheek rash in kids. In persons with weakened immune systems and blood disorders, infection can lead to a low blood count. The disease may also heighten the risk of miscarriage early in pregnancy. The third study revealed that the infection has been observed in teens and kids with sickle cell anemia in Georgia. The researchers involved emphasized the need to monitor children with sickle cell and B19 for complications, noting that early red blood cell transfusion could prevent severe outcomes. Overall, the researchers involved in all studies encourage healthcare providers to promote measures preventing infection while remaining hypervigilant for evidence of severe swelling or signs of decreased fetal movement when caring for pregnant individuals, as this could be linked to B19. As more infectious diseases emerge and re-emerge, there is a growing need for companies like Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to ramp up their R&D programs so that viable immune therapies targeting many of these infectious diseases can be readily available to the vulnerable populations that need these treatments.

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious diseases and autoimmune diseases.

In collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences (MPG) and the University Medical Center Göttingen (UMG), both in Germany, Scinai is developing a pipeline of innovative nanosized antibody (NanoAb) therapies addressing diseases underserved by current treatments and with large and growing markets, such as COVID-19, asthma and psoriasis.

NanoAbs, also known as VHH-antibodies or Nanobodies, are alpaca-derived nanosized antibodies that exhibit multiple significant competitive advantages over existing antibody therapies, including stability at high temperatures, superior binding affinity, more effective and convenient routes of administration and efficient production. Scinai is uniquely positioned to advance nanosized antibody innovation from R&D through commercialization.

The company’s highly experienced and successful pharmaceutical industry leadership team includes former senior executives from Novartis, GSK and Bristol-Myers Squibb.

Since its founding, Scinai has executed eight clinical trials, including a seven-country, 12,400-participant Phase 3 trial of a prior influenza vaccine candidate, and it built, owns and operates a 20,000 sq. ft. state-of-the-art GMP biologics manufacturing facility housing its laboratories, production facilities and offices.

Lead Candidate: Inhaled COVID-19 NanoAb

In December 2021, Scinai signed definitive agreements with the Max Planck Society – parent organization of the Max Planck Institute for Multidisciplinary Sciences– and the UMG to enter a strategic collaboration for the development and commercialization of innovative COVID-19 NanoAbs.

The company is planning a rapid development path that leverages its expertise and capabilities in biological drug development and manufacturing. Scinai anticipates preclinical proof-of-concept results for an inhaled COVID-19 NanoAb by the end of 2022, with initial Phase 1/2a human clinical trial results expected in 2023.

The intended inhaled mechanism of delivery of Scinai’s COVID-19 NanoAb formulation may serve as a significant differentiator when compared to approved monoclonal antibodies, which are injected. Inhaled delivery has shown to be cheaper, more convenient and likely safer for patients and providers.

NanoAb Pipeline: Psoriasis, Asthma and More

The COVID-19 NanoAb development agreement is part of a broader five-year research collaboration agreement signed in March 2022 covering discovery, development and commercialization of NanoAbs for several other disease indications with large market medical needs, including asthma, psoriasis, macular degeneration and psoriatic arthritis.

Scinai has an exclusive worldwide license for development and commercialization of COVID-19 NanoAbs and exclusive options for similar worldwide licenses for NanoAbs for the above mentioned additional large market disorders currently underserved by approved therapeutic antibodies.

Academic research teams from MPG and UMG have verified strong affinity by the new NanoAbs to their biological target molecules and high thermostability. They have also demonstrated strong neutralization by several NanoAb candidates of their respective target molecules. Neutralization studies of the other NanoAbs are expected to begin later in 2022.

Based on the promising results, Scinai will focus development efforts beginning with the following NanoAbs:

  • NanoAbs targeting IL-17 as drug candidates for the potential treatment of psoriasis and psoriatic arthritis
  • NanoAbs targeting IL-13 and NanoAbs targeting TSLP as drug candidates for the potential treatment of asthma

These are conditions for which the antibody target is validated by existing treatments and the mechanism of action is well understood. Both represent large medical needs and growing markets. Scinai anticipates preclinical proof-of-concept for at least one of these NanoAbs in 2023. This is in addition to the aforementioned human clinical Phase 1/2a for the inhaled COVID-19 NanoAb therapy, which is also anticipated in 2023.

CDMO Services

While NanoAb pipeline development is Scinai’s core focus, the company also offers its cGMP manufacturing facility, aseptic fill and finish suite, laboratories and experienced professionals for contract development and manufacturing organization (CDMO) services. This offering is designed to keep the Scinai team abreast of the latest industry developments and trends while building experience and generating revenue to support the company’s NanoAb pipeline development.

Market Opportunity

COVID-19 treatment, target of the company’s lead NanoAb therapy candidate, had an estimated market size of $22 billion in 2021.

Future Scinai drug candidates will target conditions with large markets growing at attractive CAGRs.

The global asthma treatment market was valued at $18.08 billion in 2019 and is projected to reach $26.01 billion by 2027, exhibiting a CAGR of 4.5% during the forecast period, according to Fortune Business Insights. The research firm predicts that the global psoriasis treatment market will grow from $26.37 billion in 2022 to $47.24 billion by 2029, exhibiting a CAGR of 8.7% over the forecast period.

Management Team

Amir Reichman is Scinai’s CEO. He previously was Head of Global Vaccines Engineering Core Technologies at GSK Vaccines in Belgium. Prior to that, he held leadership roles at Novartis Vaccines’ Global Vaccines Supply Chain Management organization. He was the first employee of NeuroDerm Ltd., a company focused on transdermal drug delivery, and served as Senior Scientist until his departure in 2009. He earned a M.Sc. in Biotechnology Engineering from Ben-Gurion University and an MBA in Finance and Health Care Management from the University of Pennsylvania’s Wharton School.

Tamar Ben-Yedidia, Ph.D., is Chief Science Officer at Scinai. She has more than 30 years of experience in immunology, with specific expertise in the development of vaccines. She began her career with Biotechnology General Ltd., working on development of a recombinant Hepatitis-B vaccine. She later joined the Weizmann Institute of Science, working on the design of a peptide-based vaccine against several pathogens. She is widely published, with numerous refereed articles and invited reviews in various scientific journals. She received her Ph.D. from the Weizmann Institute.

Elad Mark is COO at Scinai. He has over 15 years of biotechnology industry experience encompassing diverse project stages including feasibility studies, conceptual and detailed design, commissioning, qualification and process validation. Prior to joining Scinai, he led Novartis’s $800 million investment in a biologics facility in Singapore. With Biopharmax and Antero, both global pharmaceutical engineering companies, he successfully led projects in Israel, China and Singapore. He holds a BSc. in Engineering from the Afeka Tel Aviv Academic College of Engineering and an MBA from the Open University of Israel.

Uri Ben-Or is CFO at Scinai. He has served as CFO with public life science companies traded on the TASE, OTC and Nasdaq. Ben-Or provides his services to Scinai through CFO Direct, a company he founded and for which he serves as CEO. He served as the VP of Finance of Glycominds, a leading biotechnology company, and as CFO of a spin-off from Telrad Networks. He also served as a Corporate Controller at Menorah Capital Markets and as an Auditor at PWC. He holds a B.A. in Business from the College of Administration, an MBA from Bar-Ilan University, and is a CPA.

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), closed Friday's trading session at $3.3, up 1.227%, on 4,163 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $87.945/$.

Recent News

Calidi Biotherapeutics Inc. (NYSE American: CLDI)

The QualityStocks Daily Newsletter would like to spotlight Calidi Biotherapeutics Inc. (NYSE American: CLDI).

Emerging therapies, advanced diagnostic tools and groundbreaking research are reshaping the fight against cancer.

Calidi Biotherapeutics uses stem cells and cell-enveloping technologies to deliver virotherapy payloads that attack cancers and leave healthy cells untouched.

RTNova is designed to address the limitations of traditional virotherapy by offering enhanced targeting, systemic delivery and immune system modulation.

Cancer continues to be a leading cause of morbidity and mortality worldwide, affecting millions of lives every year. While advances in prevention, early detection and treatment have made strides in reducing the global cancer burden, innovation remains critical to achieving further breakthroughs. Emerging therapies, advanced diagnostic tools and groundbreaking research are reshaping the fight against cancer, offering new hope for patients and their families. A compelling example of this progress is the work of Calidi Biotherapeutics (NYSE American: CLDI), whose recent data on its RTNova(TM) systemic enveloped virotherapy technology demonstrates the potential of cutting-edge solutions to revolutionize cancer care (https://ibn.fm/X06dh).

Calidi Biotherapeutics Inc. (NYSE American: CLDI) is a clinical-stage immuno-oncology company pioneering proprietary technology that empowers the immune system to combat cancer. Calidi’s innovative, off-the-shelf cell-based platforms use allogeneic stem cells to deliver potent oncolytic viruses (OVs) across multiple oncology indications, including high-grade glioma (brain cancers) and solid tumors. In addition, Calidi has presented a breakthrough systemic technology, RTNova, which utilizes an exteracellular enveloped virotherapy. RTNova is pre-clinical and has been extremely well-received by market analysts and large-cap biopharma – opening the door for potential collaboration.

These cell-based platforms are engineered to protect, amplify, and enhance the efficacy of oncolytic viruses, resulting in improved patient safety and potentially advancing treatment outcomes for metastatic disease. By employing a dual approach that combines OV delivery with immune activation, Calidi’s therapies aim to not only treat but potentially prevent the spread of metastatic cancers.

The company’s development pipeline leverages this technology to address pressing needs in cancers such as glioblastoma (brain cancer), metastatic melanoma, triple-negative breast cancer, head & neck cancer, and lung cancer. Calidi’s approach has shown early signals of efficacy and safety, establishing it as a distinctive player in the growing OV market, which is projected to increase significantly in value over the next decade.

Calidi is headquartered in San Diego, California.

Products

Calidi’s product pipeline includes advanced cell-based platforms targeting a variety of oncology indications, each designed to harness the power of oncolytic virotherapy for improved cancer treatment outcomes.

  • NeuroNova (CLD-101): A platform designed for treating high-grade gliomas (HGG), NeuroNova employs neuronal stem cells combined with an engineered adenovirus (CRAD-s-Pk7) to selectively target glioma cells. After a successful Phase 1 safety study in newly diagnosed HGG, NeuroNova has now progressed into Phase 1/1b trials for recurrent cases. FDA clearance for a Phase 1b/2 trial at Northwestern University was received in September 2024, with patient enrollment expected to begin in Q1 2025. This trial will utilize multiple-dose intracerebral administration to maximize safety and efficacy in newly diagnosed HGG patients.
  • SuperNova (CLD-201): Built on Calidi’s foundational technology, SuperNova utilizes an engineered Vaccinia virus (CAL1) delivered via allogeneic adipose-derived mesenchymal stem cells to target advanced solid tumors, including head & neck, triple-negative breast cancer, and soft tissue sarcomas. Early studies with autologous stem cells demonstrated both safety and promising efficacy, and Calidi plans to begin a Phase 1 trial with multiple dose regimens for SuperNova in the coming months.
  • RTNova (CLD-400): Calidi’s systemic delivery platform for lung and metastatic cancers, RTNova employs an extracellular enveloped virotherapy (envRT-01) technology for intravenous (IV) administration, simplifying the treatment process and expanding its potential applications. Currently in preclinical stages, RTNova focuses on demonstrating efficacy and safety through systemic administration. A clinical trial targeting metastatic lung cancer is anticipated for Q2 2026, using a single-arm monotherapy with dose escalation. Calidi has partnered with SIGA Technologies (NASDAQ: SIGA) to support the development of this program.

Market Opportunity

The global oncology drugs market was valued at $201.75 billion in 2023 and is projected to grow to $518.25 billion by 2032, with a CAGR of 11.3%. The oncolytic virotherapy market in particular is growing rapidly, driven by increasing approval rates and significant unmet needs.

The market for OV treatments is expected to expand from one approved product generating $150 million in the U.S. in 2021 to 6-8 approved therapies generating $2.4 billion by 2030. As a leader in OV technology, Calidi is well-positioned to address these high-demand areas in oncology.

Alongside global trends, the American Cancer Society projects nearly two million new cancer diagnoses in the U.S. in 2024, reflecting a 28% increase since 2010. This underscores the urgent need for novel therapies that not only treat disease progression but also enhance patient quality of life, reinforcing the demand for Calidi’s innovative approaches.

Management Team

Allan Camaisa, CEO, Chairman, and co-founder, is a seasoned leader with extensive experience in scaling businesses to successful exits. Mr. Camaisa previously led High Technology Solutions, growing it from two employees to over 500 with $50 million in revenue. He also served as CEO of Parallel6 Inc. and is a U.S. Naval Academy graduate with further studies at Harvard Business School.

Antonio Santidrian, Ph.D., Chief Scientific Officer, leads all research and development initiatives at Calidi and is the coinventor of the company’s CLD-201 (Supernova) and CLD-400 (RTNova) platforms. Since joining Calidi in 2015, he has applied his 20+ years of expertise in academia and biotech, focusing on anti-cancer translational research, to drive the company’s innovative drug pipeline. Before Calidi, Dr. Santidrian led translational studies at The Scripps Research Institute, advancing treatments for breast cancer metastasis, and contributed to the development of ACADRA for chronic lymphocytic leukemia (CLL) at the University of Barcelona, Spain.

Boris Minev, M.D., President of Medical and Scientific Affairs, is a renowned physician-scientist with expertise in Immuno-Oncology, stem cell biology, and oncolytic viruses. Previously, Dr. Minev served as Director of Immunotherapy and Translational Oncology at Genelux Corporation and remains an adjunct professor at the Moores UCSD Cancer Center. His background includes research at the National Cancer Institute.

Andrew Jackson, CFO, has held executive finance roles with experience in biotech and clinical-stage companies, including Eterna Therapeutics and Ra Medical Systems. Mr. Jackson holds an MSBA in Finance from San Diego State University and a BSB in Accounting from the University of Minnesota.

Calidi Biotherapeutics Inc. (NYSE American: CLDI), closed Friday's trading session at $2.1, up 4.4776%, on 1,162,865 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.73/$26.30.

Recent News

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF)

The QualityStocks Daily Newsletter would like to spotlight Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF).

Earlier this week, the Chinese government announced a ban on the export of gallium and germanium to the United States. The announcement by the Chinese government was made in response to America imposing new export restrictions that target the East-Asian country's ability to manufacture advanced semiconductors. This crack down affected more than 100 Chinese firms, including SiCarrier and Piotech, which manufacture advanced chips. The East-Asian country has also made the decision to apply a stricter review of its graphite exports to America. Data from Graphite India also shows that India is a big growth driver of steel demand. This is primarily driven by investments across sectors that consume steel. KK Bangur, the Chairman of Graphite India, expects that the company will continue benefitting from the adoption of electric arc furnace manufacturing processes by the steel industry as more countries around the world implement decarbonization strategies. Aside from Graphite India and HEG, there is a pair of other producers that have almost double the capacity of these graphite companies. These are Resonac, formerly known as Showa Denko; and GrafTech International, formerly known as Union Carbide. As other entities like Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) progress in the development of new graphite mines, the supply gap created by the Chinese export restrictions will be more than covered.

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) is a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space. The company aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications.

Reflex Advanced Materials is based in Vancouver, British Columbia. Its project portfolio includes the Ruby Graphite Deposit in Montana and the ZigZag Lithium Property in Ontario.

Projects

Ruby Graphite Project

Located in a mining-friendly jurisdiction in southwest Montana, the Ruby Graphite Deposit is a low cost, rapid re-entry opportunity that produced roughly 2,400 tons of graphite from 1902 to 1948. Reflex Advanced Materials holds mining rights for 755 hectares at the Ruby Graphite Project, with 96 federal lode mining claims. Recent samples assay at 95.8% to 98.4% total carbon.

The site is notable as the only combined U.S. graphite flake and vein graphite source. Vein graphite is ideal for energy storage applications, because it requires fewer steps to achieve purity than synthetic alternatives and is therefore far less environmentally damaging. This is expected to play a key role in the project’s development as demand for electric vehicles continues to surge.

In March 2023, the company announced its submittal of permit applications to the Bureau of Land Management in respect of its exploration of the Ruby Graphite Project. Its initial drill program, expected to take place in the summer of 2023, includes plans for 3,500 total meters of drilling, cored to an average depth of 130 meters. The targets for this drill program have been identified using historical data from original mine operations and data gathered for the initial 43-101 technical report on the project, dated January 31, 2023.

ZigZag Lithium Property

Located in the Thunder Bay Mining Division of Ontario, the ZigZag Lithium Property consists of eight mining claims spanning roughly 2,710 hectares. Mineralization at the property, most notably lithium, is based in pegmatite dikes and concentrated in spodumene crystals, which are consistent throughout the entire unit.

Spodumene is readily observable in outcrops and in drill cores, with crystal sizes ranging from 3-15cm, on average.

Reflex Advanced Materials and American Energy Technologies Company Metallurgical Partnership

Reflex Advanced Materials has entered into a material processing agreement with American Energy Technologies Co., which is based in Arlington Heights, Illinois, to conduct metallurgical testwork with the goal of creating a technical support data package for Reflex’s target customer base, U.S. Federal agencies and qualification programs with hi-tech customers in the battery and battery storage business.

The resulting coated, spherionized, purified graphite (CSPG) material that is expected to be created from the aforementioned tests will be used to provide potential customers of CSPG with samples so that they can begin the material qualification process.

Market Opportunity

Graphite is an ideal battery anode and has dominated the market since the proliferation of lithium-ion batteries. Despite this demand, there is currently no significant production of lithium-ion battery anode material in North America.

Instead, most graphite sold in North America today is sourced from Chinese producers. U.S. President Joe Biden highlighted this sourcing disparity in a 2022 address:

“The United Stated depends on unreliable foreign sources for many of the strategic and critical materials necessary for the clean energy transition – such as lithium, nickel, cobalt, graphite and manganese for large-capacity batteries,” he said. “Demand for such materials is projected to increase exponentially as the world transitions to a clean energy economy.”

The U.S. Department of Energy is in the process of awarding $2.8 billion to expand domestic manufacturing of batteries for electric vehicles and combat this foreign dependency. Reflex Advanced Materials has identified its Ruby Graphite Project as a prime candidate for U.S.-sponsored initiatives due to the rarity and scarcity of natural graphite deposits in the country.

Processing graphite domestically in the U.S. is expected to provide Reflex Advanced Materials a competitive advantage as manufacturers begin to seek out American supply in the face of increased diplomatic tension. This is critical, as a rise in anode demand is expected to fuel a shortage of 8 million tonnes of graphite by 2040. World Bank Group projects 494% growth in total graphite demand by 2050.

Leadership Team

Paul Gorman is the CEO and a Director of Reflex Advanced Materials. He brings to the company over 25 years of experience in junior mining finance, public listings, viability assessment and operational rationalization. For 18 years, Mr. Gorman served as president and managing partner of Riverbank Capital, where he played an instrumental role in raising more than $85 million for small-cap companies. In 2008, he funded Industrial Minerals Inc. (later Northern Graphite) and served in an advisory role for four other graphite companies, contributing significantly to the revitalization of the junior graphite space in North America. Mr. Gorman founded Mega Graphite Inc. in 2009 and has served as chief executive for three other companies.

Tasheel Jeerh, CPA, is the company’s CFO. He is a finance and accounting professional with over a decade of experience spanning both public and private sectors. Prior to joining Reflex Advanced Materials, Mr. Jeerh played a pivotal role in the growth of a private upstream oil and gas firm, dealing with over $2 billion in M&A activity and $1 billion in financing activities. He gained his designation at PricewaterhouseCoopers, where he worked as a manager in the assurance practice.

Greg Bell is Project Manager for Reflex Advanced Materials. He is a multi-disciplined engineering management professional with more than 40 years of experience in the natural resources sector. Mr. Bell has successfully built and managed several start-up operations in various capacities. He has been active in graphite and lithium exploration for the past seven years.

Christopher W. Hill leads the company’s Corporate Development initiatives. He is an investor and entrepreneur with over a decade of experience in the capital markets. Mr. Hill began his career as an investment advisor and then began to consult and advise private companies on their paths to becoming publicly traded. He specializes in corporate development and strategic financing utilizing his large network in the capital markets.

Reflex Advanced Materials Corp. (RFLXF), closed Friday's trading session at $0.02155, up 4.1063%, on 40,000 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.018/$0.2269.

Recent News

Horizon Fintex | Upstream

The QualityStocks Daily Newsletter would like to spotlight Horizon Fintex | Upstream

Upstream published a blog today that discussed accessibility and security as paramount in today's digital economy for investors managing their portfolios. "Upstream, a MERJ Exchange market and stock trading app, leverages Signing Key technology to give investors complete control over their assets right from the palm of their hands," the blog reads.

"By using Upstream's Signing Key, investors gain: Full Control Over Assets: You, and only you, can authorize trades or transfers. This empowers investors to manage their assets while reducing the risk of unauthorized activity. Enhanced Security: Local storage and biometric authentication create a robust defense against potential threats. Convenience: Manage your portfolio anytime, anywhere, directly from your phone."

To view the full blog, visit https://ibn.fm/R6PDS

Horizon Fintex is a software business specializing in compliant securities solutions. The company aims to facilitate the future of capital markets by leveraging the regulatory experience of Wall Street bankers and the proven track record of technology veterans to bring focus to compliance, efficiency, security and transparency.

Horizon’s flagship product is the revolutionary trading app ‘Upstream’, a MERJ Exchange Market, and the first regulated market powered by a blockchain to offer both digital securities and NFT trading. Upstream traders experience T+0 settlement, best bids and offers displayed on a transparent public orderbook that prevents predatory market practices – all from a user-friendly trading app.

Products

Horizon Fintex offers a full suite of end-to-end blockchain-enhanced software solutions to create a seamless experience for both issuers and investors. Its product suite includes:

  • Securitization & IssuanceETSware is an end-to-end Electronic Trading System streamlining capital raising from primary issuance through compliant secondary trading.
  • KYC Compliance OnboardingKYCware is a white label Know Your Customer (KYC) and Anti-Money Laundering (AML) compliance software solution offering best-in-class cryptographic security to compliantly onboard and verify user identity through a smartphone application.
  • AML Screening SoftwareAMLCop offers advanced Anti-Money Laundering (AML) software to streamline the verification of user details against a proprietary database of global sanctions, politically exposed persons (PEPs) and watchlists.
  • Cap. Table Management ToolsCustodyWare equips registered U.S. transfer agents with next-generation cap. table management software to manage securities on behalf of their clients pursuant to an SEC-registered or exempt securities offering.
  • Exchange & Trading App TechnologyOpen Order Book offers Ethereum blockchain securities exchange software to power the next generation of trading venues for digital assets.

Upstream – The Horizon-Powered Trading App

Upstream is a joint venture with MERJ Exchange (merj.exchange), an affiliate of the World Federation of Exchanges.

Upstream aims to be the premiere global trading hub offering issuers around the world exposure to a digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD (fiat) to increase liquidity and enhance price discovery; while also offering investors access to dual-listed companies, IPOs, crowdfunded companies, U.S. & Int’l. equities, digital coupons and NFTs directly from a user-friendly trading app.

Upstream aims to unlock liquidity for investors of all levels while offering industry-leading levels of transparency, accessibility and investor protections enforced using Ethereum blockchain technology.

Management Team

Brian Collins is the CEO of Horizon Fintex. He founded the company in 2010. From 1999-2010, Mr. Collins was CEO of Abbey Technology in Switzerland, specializing in the design of trading software for Swiss banks. Prior to this, he worked for Credit Suisse in Zürich, designing and building proprietary equity trading solutions. Mr. Collins graduated in 1990 with a BS in Computer Systems from the University of Limerick, Ireland.

Mark Elenowitz is the company’s President. He is a Wall Street veteran with over 29 years of experience. Mr. Elenowitz was the co-founder of a U.S. broker dealer and is Managing Director of two U.S. broker dealers, responsible for advising clients on compliance, capital structure and capital market navigation. He was responsible for leading the first successful Reg A+ IPO of a company to list on the NYSE and others which listed directly onto Nasdaq. He is a noted speaker at Small Cap and Reg A events, including the SEC Small Business Forum, and has been profiled in BusinessWeek and CNBC, as well as several other publications. Mr. Elenowitz is a graduate of the University of Maryland School of Business and Management with a BS in Finance and holds Series 24, 62, 63, 79, 82 and 99 licenses.

Dr. Andrew Le Gear is the CTO of Horizon Fintex. Prior to joining the company in 2013, he worked as a software engineer with Dell Inc. (2012-2013) and Lehman Brothers and Nomura Plc. (2007-2012). Dr. Le Gear was a co-founder of Juneberi Ltd., a research-driven software tech start-up (2004-2007). He graduated in 2006 with a Ph.D. in Computer Science from the University of Limerick, Ireland.

Peter Hall is the company’s CIO. Prior to joining Horizon Fintex in 2011, he worked at Microsoft (2008-2011), Atos Origin (2004-2008) and AIT Group Plc. (1998-2002). Mr. Hall has held CISSP certification since 2010. He graduated from the University of Sheffield, UK in 1995 and earned an MS from the University College London in 2006.

Mike Boswell is the CFO of Horizon Fintex. A Wall Street veteran, he co-founded a U.S. broker dealer and served as Chief Compliance Officer. Mr. Boswell was also Managing Director of TriPoint Capital Advisors, a merchant banking and financial consulting company, and CFO of Mission Solutions Group, a privately held defense sector firm. He earned an MBA from John Hopkins University and a BS in Mechanical Engineering from the University of Maryland. Mr. Boswell holds Series 24, 62, 63, 79, 82 and 99 licenses.

Recent News

chart

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX)

The QualityStocks Daily Newsletter would like to spotlight McEwen Mining Inc. (NYSE: MUX) (TSX: MUX).

Sam Altman, the CEO of OpenAI, has voiced his confidence in President-elect Donald Trump supporting the AI sector and ensuring that America, together with its allies, retain pole position in this nascent industry. Altman was speaking during a recent interview with Fox News. During the interview, Sam Altman highlighted the fact that support in the form of massive infrastructure needed to be directed to the artificial intelligence industry. Altman added that he was certain that the incoming administration would provide this needed support. He reiterated that the massive infrastructure was necessary to enable the U.S. to stamp its leadership on AI technology and AI capabilities. OpenAI, the company that Sam Altman heads, has risen in prominence as the years have gone by. This is because the firm has played a key role in the AI space from the time its flagship innovation ChatGPT was released onto the market. ChatGPT opened the floodgates to generative AI and other use-cases for artificial intelligence. It should be noted that Elon Musk, another billionaire, was a cofounder of OpenAI. He left the company and recently went to court to stop OpenAI from pivoting to a profit-making enterprise as it had been founded as a nonprofit. The case is still ongoing. OpenAI's legal issues with Elon Musk aside, the race to establish AI infrastructure is on. Tech giants like Microsoft, Meta Platforms, Alphabet Inc., Amazon and so many others are frantically building out data centers and other attendant systems in order to stamp their mark on the AI field. This race to set up AI infrastructure and applications has created market opportunities for companies like McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) that extract the minerals critical to the AI industry.

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is an asset rich diversified gold and silver producer in the Americas with a large exposure to copper through its subsidiary, McEwen Copper, owner of the Los Azules copper deposit in Argentina, believed to be the 8th largest undeveloped copper resource in the world.

Led by a management team with a track record of success, MUX owns and operates mines in some of the most prolific gold producing regions of the Americas. The company proactively took cost-saving measures months ago to lower expenses and increase production across its portfolio of gold assets, driving some production costs below industry averages. Gold and copper prices, already in an upswing, are forecast to enter an explosive uptrend over the next couple years. Drawing from its experience, McEwen Mining planned, prepared and laid the groundwork to capitalize on this emerging opportunity.

The company currently holds a Zacks Rank #1 (Strong Buy), placing it in the top 5% of over 4,000 stocks ranked by Zacks, based on trends in earnings estimate revisions and EPS surprises. Seldom is management so aligned with investors’ interests and committed to the company’s success. With a combined investment of over $220 million, CEO Rob McEwen holds a 17% ownership stake in McEwen Mining and a 13% ownership in McEwen Copper. Acclaimed in the mining industry, McEwen founded Goldcorp, where he increased the company’s market capitalization 160 times – from $50 million to over $8 billion. That same vision and tenacity led MUX in creating McEwen Copper.

For McEwen Mining shareholders, beyond the company’s exposure to gold upsurges, its 47.7% stake in McEwen Copper is expected to be a blockbuster, turbocharging MUX by creating the world’s next prolific copper unicorn.

McEwen Copper

With continuous industrial need, new critical demand for copper is rapidly emerging, increasingly driven by the green energy transition. The price of copper rose from a low of about $2 per pound in 2020 to over $4.60 per pound in May 2024, and strong demand is expected to intensify. A study by S&P Global, titled The Future of Copper: Will the Looming Supply Gap Short-circuit the Energy Transition?, projects global copper demand to nearly double over the next decade, from 25 million metric tons today to about 50 million metric tons by 2035. Based on current trends, S&P Global forecasts annual supply shortfalls to reach nearly 10 million metric tons in 2035.

McEwen Mining owns a 47.7% equity stake in McEwen Copper, the holder of a 100% interest in the Los Azules copper project in San Juan, Argentina, which is ranked the 8th largest undeveloped copper deposit in the world. Current copper resources at Los Azules are estimated at 10.9 billion pounds at a grade of 0.40% Cu (Indicated category) and an additional 26.7 billion pounds at a grade of 0.31% Cu (Inferred category). McEwen Copper also owns a copper exploration project in Nevada, USA, called Elder Creek.

In a 2023 Preliminary Economic Assessment (PEA), Los Azules was estimated to have a 27-year life, producing an average of 322 million lbs. of copper cathode annually, at a cash cost of $1.07 per lb. of copper, in the lowest quartile of the copper cost curve. The project could ultimately become an even larger mine with a longer life, since the extent of mineralization has not been fully assessed on the property.

The project’s 2023 PEA presents a distinctly different development strategy from a prior PEA published in 2017. By proposing a heap leach project using solvent extraction-electrowinning instead of the previously detailed mine with a conventional mill and flotation concentrator, McEwen Copper aims to decrease its environmental footprint and reduce permitting risk, albeit with a lower overall copper recovery, slightly higher unit costs and a delay in immediate cashflow due to extended leach cycles.

After securing a $25 million investment from mining giant Rio Tinto’s technology arm, Nuton LLC, McEwen Copper closed its non-brokered, private placement offering of $82 million in August 2022. Shortly after, in February 2023, Nuton agreed to invest an additional $30 million into McEwen Copper, and in October 2023, Nuton once again expanded its stake, investing an additional $10 million to bring its ownership position in McEwen Copper to 14.5%.

“We are extremely pleased to have Nuton’s strong continued participation in McEwen Copper,” Rob McEwen stated in a news release. “Together we are exploring new technologies that save energy, water, time and capital in the pursuit of delivering green copper to Argentina and the world, a product that will contribute to the electrification of transportation and the protection of our atmosphere.”

Also in February 2023, FCA Argentina S.A., a subsidiary of Stellantis N.V., one of the world’s leading automakers, invested ARS $30 billion in McEwen Copper. In October 2023, Stellantis invested an additional ARS $42 billion, bringing its current stake in McEwen Copper to 19.4%.

“We are delighted to have Stellantis as a partner in the future development of our Los Azules copper project,” Rob McEwen said of the investment. “Together, we share a vision to build a mine for the future based on regenerative principles that can achieve net-zero carbon emissions by 2038.”

Following the capital raise, McEwen Copper is well-funded to advance its Los Azules Project, with a Feasibility Study planned for Q1 2025. MUX strategically reduced its interest to increase its treasury, in order to reduce debt and fund the further development of its gold and silver assets.

Gold & Silver Projects

The Fox Complex

McEwen Mining owns a 100% stake in the Fox Complex in the heart of a prolific gold district in Timmins, Canada.

“When MUX bought the Fox Complex, in late 2017, it was a distressed asset with a history of high operating cost/oz. While it has taken longer than I expected, the cost to produce an ounce of gold is significantly lower,” CEO Rob McEwen stated in a news release.

McEwen Mining issued 2024 guidance for its cash cost/oz at the Fox Complex of $1,225-1,325 on annual production of 40,000-42,000 GEOs. Fox Complex produced 44,450 GEOs in 2023, which was within the company’s guidance range.

Located in one of the most prolific gold production areas in the world, along the Destor-Porcupine Fault Zone within the Abitibi Greenstone Belt, the Fox Complex includes the Black Fox mine and Froome mine which together have yielded over 1,000,000 ounces of gold to date. Also, the complex includes the Grey Fox and Stock deposits that have over 1,800,000 ounces in gold resources. The 2.7-billion-year-old Abitibi Greenstone Belt, formed by ancient volcanic activity, has proved to be one of the world’s richest and most abundant gold regions, with a total gold content currently estimated at over 300 million ounces.

In 2024, MUX commenced development of underground ramp access to the Stock orebodies at the Fox Complex. This development will become the primary source of feed following the completion of mining the Froome deposit in 2026. As part of the future mining sequence initiative, the company has already reported a 31% year-over-year increase of gold resources at Stock West and Stock Main (historical Stock Mine), with confirmation of good grading structures plunging to depth. It has also identified Stock East as a potential new near-term source of future revenue.

The Gold Bar Mine

McEwen Mining owns a 100% stake in the Gold Bar mine, located in an area well known for gold production, the southern Roberts Mountains of the Battle Mountain-Eureka-Cortez gold trend in Eureka County, Central Nevada. The Gold Bar mine is on the same geological structure, 25 miles south of Nevada Gold Mines, a Barrick-Newmont joint venture, part of the Cortez-Goldrush complex. This complex contains estimated reserves and resources of over 50 million gold ounces, with an annual production of 1,000,000 gold ounces.

Gold Bar had been mined between 1991 and 1994, producing 134,000 gold ounces. A new facility was built by MUX in 2019. Gold Bar accounted for 42,700 GEOs in 2023, within the company’s guidance for the year. For 2024, McEwen Mining issued guidance of 40,000-43,000 at a cash cost of $1,450-1,550. The first half of the year is expected to deliver higher production relative to the second half, due to a scheduled waste stripping phase in the Pick pit, in preparation for the 2025 mining program.

Notably, in April 2024, McEwen Mining announced its entry into a definitive agreement and plan of merger with Timberline Resources Corporation (TSX.V: TBR) (OTCQB: TLRS) in a transaction valued at roughly $18.8 million. The merger with Timberline is expected to augment McEwen’s existing portfolio of development and exploration projects in Nevada, leveraging synergies between Timberline’s projects and the Company’s Gold Bar mine.

El Gallo/Fenix

Project Fenix is the proposed redevelopment plan for McEwen Mining’s El Gallo Complex in Mexico. There is a long history of mining in this region. MUX began operating it as an open pit, heap leach mine in 2013, which produced 281,000 gold equivalent ounces at average cash cost of $655 per ounce. Due to the transition to deeper sulfide mineralization that is not amenable to heap leaching, mining activities ceased in the second quarter of 2018 and residual heap leaching followed until mid-2022. The redevelopment plan envisions constructing a mill at the existing mine site that will initially reprocess the existing heap leach material, then transition to open pit mining and processing of the sulphide mineralization. The company recently acquired a complete process plant on very advantageous terms that has considerably reduced the projected capital requirements for the project.

CEO Rob McEwen stated in a news release, “This acquisition has made Fenix more attractive to build and could provide a new long life mine for McEwen Mining.”

The initial development approach is to build a mill to reprocess the material on the heap leach pad and produce approximately 17,000 oz of gold annually for eight years. Construction of the Fenix project is expected to begin in the second half of 2024.

San José Mine

McEwen Mining is a 49% owner and non-operator of the San José gold and silver mine, located in Santa Cruz province, Argentina, encircling Newmont’s prolific Cerro Negro (approx. 300,000 gold ounces produced in 2023). This high-grade underground mine has been operating since 2007 and currently has an expected life of six years with a reserve grade of 296 gpt silver and 5.4 gpt gold.

Exploration is continuing to extend high-grade veins and discover new veins at the complex. San José’s drilling programs to define additional resources and reserves have a long history of success due to a high vein density, aided by good geophysical response from hidden veins.

Production guidance for 2024 for MUX’s 49% interest is 50,000-60,000 GEOs. As a minority shareholder in the mine, MUX equity accounts for its investment in San José, and receives 49% of the dividends from the mine’s free cash flow.

Market Outlook

Mining stocks suffered significant losses in the wake of the COVID-19 pandemic. However, this has turned, and many analysts now forecast a gold bull market in 2024 and beyond.

“The operating challenges we faced in recent years have severely damaged our credibility with our shareholders and the market. As a result, few investors have taken a close look recently at our assets,” Rob McEwen said in a news release. “If they did, I believe some would see the potential value that I see today… I believe there is considerable potential value in MUX, and that is a big reason why I have a personal financial commitment of $220 million in MUX and McEwen Copper.”

Management Team

Robert R. McEwen is Chairman, CEO and Chief Owner of McEwen Mining. He has been associated with the gold industry all his career, with his first 18 years in the investment industry and, since 1990, as CEO of several gold mining companies. He founded Goldcorp and took that company from a $50 million market capitalization to more than $8 billion. He owns 17% of McEwen Mining and is in complete alignment with investors – his investment in MUX and McEwen Copper is $220 million and he takes an annual salary of only $1. He was awarded the Order of Canada and the Queen Elizabeth’s Diamond Jubilee Award, was inducted into the Mining Hall of Fame, was named an Ernst and Young Entrepreneur of the Year and has Honorary Doctor of Law degrees from York University and Western University.

William Shaver is interim COO and a Director of McEwen Mining. He has decades of management and executive experience in mine design, construction and operations. He was a founder of Dynatec Corporation, which became one of the leading contracting and mine operating groups in North America. In 2013, he was recognized as Ernst and Young Entrepreneur of the Year. Most recently, he served as COO of INV Metals. He is a Professional Engineer with a B.Sc. in Mining Engineering from Queens University.

Perry Ing is interim CFO at McEwen Mining. He has 25 years of experience in the Canadian mining industry. Over the past 15 years, he has held positions as CFO of Mountain Province Diamonds, Kirkland Lake Gold and McEwen Mining. Prior to that, he worked at Barrick Gold and Goldcorp and started his career in the mining practice at PwC. He has a Bachelor of Commerce from the University of Toronto and is a Chartered Professional Accountant in Canada and Certified Professional Accountant in the U.S.

Adrian Blanco S. is the company’s Director of Operations for America and Mexico. He has extensive international experience in several industrial sectors and has held executive positions in Mexico, the United States, Peru and Argentina. He joined the McEwen Mining team in 2015 and has led a successful business transformation toward operational discipline, best business practices and financial profitability at subsidiaries Compañia Minera Pangea and McEwen Mining Nevada. He graduated from an Executive Management Program at IPADE and Harvard Business School.

Michael Meding is Vice President and General Manager of McEwen Copper. He has over 20 years of international experience, primarily with major mining companies such as Barrick Gold and Trafigura, including extensive experience with project development and operations in Argentina. While at Barrick Gold’s Veladero mine in Argentina, Mr. Meding played a key role in the turnaround, extension of the mine life and subsequent strategic partnering with Shandong Gold. He holds an MBA from Indiana University in Pennsylvania and an MBA from the Leipzig Graduate School of Management in Germany.

McEwen Mining Inc. (NYSE: MUX), closed Friday's trading session at $8.42, off by 3.7714%, on 389,441 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $5.92/$12.50.

Recent News

Brera Holdings PLC (NASDAQ: BREA)

The QualityStocks Daily Newsletter would like to spotlight Brera Holdings PLC(NASDAQ: BREA).

Brera Holdings (NASDAQ: BREA) is an Ireland-based, international holding company rapidly expanding its global portfolio of men's and women's sports clubs through a multi-club ownership approach. The company was featured in an article that discussed its optimism in the future of sports ownership and included excerpts of management insights shared at the recent Sportico "Invest in Sports" Conference in New York City. "The growth of multi-club ownership and private equity is revolutionizing sports," said Brera Holdings' CEO Pierre Galoppi. "We believe that as more companies engage and provide resources, clubs can advance to more competitive leagues, increasing revenues and valuations. Rising valuations and uncorrelated returns are drawing attention from corporate investors, and we expect to see sports holding companies with diversified cash flows emerge as the landscape evolves."

To view the full article, visit https://ibn.fm/I8OsN

Brera Holdings PLC (NASDAQ: BREA) is an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership approach. The company capitalizes on opportunities to earn tournament prizes, secure sponsorships, collect transfer fees, provide professional sports consulting services, and enhance the valuation of its clubs.

Brera Holdings builds on the legacy of Brera FC, an international football club (referred to as soccer in the U.S.), that it acquired in July 2022. Established in 2000 and based in Milan, Italy, Brera FC has distinguished itself by cultivating an alternative football legacy. In October 2024, the Internet Marketing Association awarded Brera FC with the Social Impact Through Soccer accolade at its IMPACT 5050 Conference, recognizing the club’s global perspective and positive contributions to society.

The company’s growth strategy focuses on unlocking value from undervalued sports clubs and talent, driving innovation, and generating socially impactful outcomes. Brera Holdings is actively expanding its Global Sports Group, acquiring professional football and other sports clubs in emerging markets such as Africa, Asia, and Europe.

By targeting top-division teams in less mainstream markets, Brera Holdings aims to strengthen its competitive position in regional tournaments, including those organized by the Union of European Football Associations (UEFA). These acquisitions are expected to enhance sponsorship revenues and create new growth opportunities.

Leveraging its expertise in capital raising and revenue generation, Brera Holdings also anticipates growing demand for its consulting services, providing advisory support to sports clubs, associations, investors, and others. Brera Holdings is headquartered in Dublin, Ireland, with additional offices in Milan, Italy.

Sporting Assets

Brera Holdings continues to grow its global sports portfolio with a series of strategic acquisitions and innovations, including the FENIX Trophy Tournament, a pan-European, non-professional football competition. Launched in September 2021 and organized by Brera FC, the tournament has been recognized by UEFA and described by BBC Sport as “the Champions League for amateurs.” In 2023, Brera FC hosted the tournament’s finals at Milan’s iconic San Siro Stadium.

In March 2023, Brera Holdings expanded into Africa by establishing Brera Tchumene FC in Mozambique. Starting in the country’s Second Division League, the team quickly earned promotion to Moçambola, Mozambique’s First Division League, by November 2023.

In April 2023, Brera Holdings further strengthened its European presence by acquiring a 90% stake in Fudbalski Klub Akademija Pandev, a first-division football team in North Macedonia. This acquisition provides access to two major UEFA competitions, solidifying the company’s position in European football.

Brera Holdings’ reach extends beyond football. In July 2023, it acquired majority ownership of UYBA Volley, an Italian Serie A1 women’s professional volleyball team, demonstrating its commitment to diversifying within top-tier sports.

In September 2023, Brera Holdings entered the Mongolian football market by acquiring Bayanzurkh Sporting Ilch FC, a Mongolian National Premier League team. For the 2024 season, the club was rebranded as Brera Ilch FC, further expanding Brera’s global footprint.

In January 2024, Brera Holdings initiated a proactive search for an Italian Serie B football club, aligning with its goal of bringing multi-club ownership opportunities to mass investors through its Nasdaq-listed shares.

In February 2024, the Brera Holdings Advisory Board was established with MLS founder and World Cup director Alan Rothenberg, luxury lifestyle executive Massimo Ferragamo, sports business leaders Paul Tosetti and Marshall Geller, and Italian football icon Giuseppe Rossi.

In June 2024, the North Macedonian women’s football club Tiverija Strumica officially became part of the Brera family with the establishment of a joint-stock company controlled by Brera Holdings called Women’s Football Club Tiverija Brera AD Strumica (“Brera Tiverija”). Brera Tiverija is now a wholly-owned subsidiary of Brera Strumica FC.

In September 2024 Brera announced that it signed an exclusive letter of intent to acquire an Italian Serie B club (the “LOI” and the “Club”). According to a CFA report published in June 2024, this expected strategic transaction, for an estimated purchase price of $21.6 million, would add first-year annual revenue of $10.8 million to Brera, and that revenue would likely increase by 25% each year for the next three years. The company’s capital valuation, projected the report, would also experience significant appreciation during this period.

In October 2024, Brera was recognized with the 2024 Social Impact Through Soccer Award at IMPACT 5050, an annual event honoring leaders and innovators who significantly impact their industries and communities. This is the second time Brera has won the award.

Market Opportunity

A report from IMARC Group, a global management consulting firm, reveals that the international football market generated approximately $3.3 billion in revenue in 2023, with projections to grow to $4.6 billion by 2032, reflecting a compound annual growth rate (CAGR) of 3.6%. Key drivers behind this growth include advancements in digitization, increasing sponsorship and partnership deals between brands and clubs, the rising interest in women’s professional soccer leagues, and the expansion of the e-sports and gaming sector.

In particular, Serie B Italian football clubs seem to present exceptionally attractive investment opportunities. As of September 2024, more than half of these clubs had appreciated between 80-100% in total market value, post-purchase.

As the world’s most-watched and most-played sport, soccer drives significant demand for football-related products and services, contributing to market growth. Broadcasting rights, sponsorships, and endorsement deals are also major revenue sources for clubs and organizations, with an expanding global fanbase generating new opportunities for financial growth, according to the report.

Management Team

With extensive experience in leadership and finance, Daniel McClory currently serves as the Executive Chairman and Director of Brera Holdings, PLC. He co-founded and held the position of Chief Executive Officer at Boustead & Company Limited, and previously served as the Managing Director, Head of Equity Capital Markets, and Head of China at Boustead Securities, LLC. Mr. McClory’s governance experience includes being a Board Director for USA Track & Field and a member of the Eastern Michigan University Champions Advisory Board. Mr. McClory’s expertise encompasses founding and financing equity capital markets, as well as navigating merger and acquisition transactions and initial public offerings. He holds a BS and MS from Eastern Michigan University, where he also received an honorary Doctor of Public Service. In addition to his professional qualifications, he is fluent in both English and Italian.

Pierre Galoppi serves as the CEO, Interim CFO, and director of Brera Holdings. With over 30 years of experience in strategic business and financial services, his career spans a variety of industries, including natural resources, aviation, cybersecurity, telecommunications, tourism, and international marketing. He has worked extensively across Latin America, the Caribbean, Canada, Europe, and the United States. Mr. Galoppi holds dual citizenship in Canada and Italy and is fluent in English, Spanish, Portuguese, Italian, and French. He earned a Bachelor of Commerce degree and an MBA from Concordia University in Montreal.

Maria Xing serves as the Head of Investments and Corporate Development. She is an executive who has specialized in MCO football (soccer) group investments for 777 Partners, where she was involved in sourcing, direct negotiations, due diligence, and closing deals, including acquiring a controlling stake in Brazilian Serie A football club, Vasco da Gama, and investing in Australian Premier League (“A-League”) side, Melbourne Victory FC. She also played a role in other professional sports franchise portfolio management, including topflight professional football clubs in Italy, France, Germany, and Belgium. Her background is in private equity, investment banking, and finance, with prior experience at The Raine Group, Credit Suisse, and EY (Ernst & Young), as well as previous sports industry experience at Liverpool Football Club in international business development. Ms. Xing earned an MBA from the Wharton School of the University of Pennsylvania and a B.S. from the New York University, Stern School of Business.

Additional Resources

Brera Holdings PLC (NASDAQ: BREA), closed Friday's trading session at $0.6156, off by 5.3214%, on 268,658 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.4999/$3.00.

Recent News

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF)

The QualityStocks Daily Newsletter would like to spotlightFathom Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF).

During this year's Responsible Investment Forum: Europe, it became clear that the conversation on ESG had shifted from how ESG data could be gathered to how best the data could be utilized. With this is mind, several general partners have focused on harnessing the competitive spirit among portfolio firms to drive improvements in ESG by demonstrating how firms perform in comparison to their peers. The ESG Data Convergence Initiative has led efforts to advance ESG benchmarking in private equity. The initiative is currently in its third year of analyzing and aggregating ESG data. Many influential managers and investors in the private equity space are involved, with over 450 GP and LP members committing to reporting on some common ESG metrics. While the benchmarks produced from the ESG data are shared with the initiative's members, they aren't shared with the public. Entities like Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) in other regions around the world could take notes from the developments in Europe and see how to integrate any helpful systems in order to advance their own ESG efforts.

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) is a publicly traded Canadian minerals exploration company focused on exploring high-grade copper and gold deposits in North America. The company owns the Storm Copper Project and the Seal Zinc Deposit in Nunavut, Canada, and is currently exploring the Buckingham Gold Vein and critical metals prospects in central Virginia. Aston Bay is also in the advanced stages of negotiation on other properties with high-grade critical minerals potential in these areas.

The company believes in responsible exploration and carries out its work programs to the highest standards of social responsibility, environmental stewardship and health and safety. Aston Bay cares about leaving a net positive impact on the communities in which it works and engages with local representatives, Indigenous groups and government agencies to build respectful relationships through dialogue and collaborative processes. Depending on the stage of exploration, these efforts may include employment, contracting, training, community benefits and other agreements.

Aston Bay conducts exploration through safe, socially and environmentally responsible and sustainable work practices. The company embeds core values of health and safety throughout its operations by adhering to strict health and safety standards and practices that meet and/or exceed industry standards and government codes and regulations.

The company is headquartered in Toronto.

Projects

Storm Copper

The high-grade Storm Copper Deposit is located 112 kilometers south of the community of Resolute Bay, Nunavut, on western Somerset Island, just south of the past-producing Polaris Pb-Zn Mine. The property comprises 173 contiguous mining claims, including the Storm Copper and Seal Zinc projects, covering an area of approximately 541,795 acres.

The property has good access to established shipping lanes, and the landscape provides favorable conditions for development of roads and a protected deep-water port. Exploration is supported through excellent infrastructure in the nearby hamlet of Resolute Bay.

Aston Bay is partnered with American West Metals (ASX: AW1) at Storm. American West is responsible for all exploration expenditures, having aggressively advanced the project toward production and earned an 80% interest. This affords excellent optionality to the company’s shareholders, as Aston Bay is free carried with no required expenditures until the completion of a bankable feasibility study.

American West recently completed an Australian JORC-compliant Maiden Resource Estimate for Storm; the North American 43-101 compliant resource estimate is expected in Q1 2024. American West is cashed up and plans a multimillion-dollar resource expansion and new discovery drilling program for the summer of 2024.

The Buckingham County Gold Project

The gold-bearing system at the Buckingham County Gold Project in Virginia lies within a belt hosting past producing mines, current gold mines and advanced gold explorations, stretching through Georgia, the Carolinas, Virginia, Nova Scotia and Newfoundland.

Buckingham hosts a “Kirkland Lake-style” high grade gold vein returning values consistently over one ounce gold per ton and is underexplored both at depth and along almost one mile of strike length. These types of veins have excellent ESG qualities, as they are typically mined using a small footprint underground method, with gold extracted using simple and environmentally friendly gravity methods.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

A report from Acumen Research and Consulting, a global provider of market intelligence and consulting services, valued the global copper market at $304.1 billion in 2022 and forecast that it will reach a market size of $496.8 billion by 2032, growing at a CAGR of 5.1% over the forecast period.

The report identifies a growing demand for copper in the electronics industry, as well as an expanding copper supply due to increasing production from existing mines and the rising number of mine development projects in developing nations, as driving factors in the rising value of the copper market.

Management Team

Thomas Ullrich is CEO and Director of Aston Bay. He has over 30 years of experience in mineral exploration and geoscience. Before joining Aston Bay, he was Chief Geologist North America for Antofagasta Minerals plc, investigating copper potential through extensive property evaluations and management of drill programs in the United States, Mexico and Canada. Prior to that, he was Senior Geologist for Almaden Minerals.

Sofia Harquail handles Investor Relations and Corporate Development at Aston Bay. She has over 15 years of experience in the private and public sectors of the mining industry. Before joining Aston Bay, she worked as a consultant for the Prospectors and Developers Association of Canada and for exempt market dealer Red Cloud Financial Services Inc. Ms. Harquail holds an M.A. from the University of Uppsala in Sweden and received her CPIR designation from the CIRI/Ivey Investor Relations Program. She also sits on the board of the Young Mining Professionals Toronto and is CSC Certified.

Aston Bay has a talented Board of Directors bringing broad experience from across the industry, encompassing resource expansion, mine development, mergers and acquisitions, and mining finance.

Ms. Jessie Liu-Ernsting has over 15 years of experience in the mining industry, spanning capital projects engineering, debt capital markets, private equity and corporate strategy at several firms, including Hudbay Minerals and Resource Capital Funds. She is currently VP Investor Relations and Communications at G Mining Ventures Corp.

Mr. Jeffrey R. Wilson has over 25 years’ experience in the mining industry, having served as a director, officer and advisor of multiple public and private companies in the mineral exploration and mining investment industries. Mr. Wilson is currently President & CEO of Precipitate Gold Corp.

Mr. Gary O’Connor has over 40 years of diverse experience as a mineral exploration and development professional in the management of successful resource projects as well as the evaluation, technical due diligence, and supervision of large mineral exploration and development projects through-out the world. While with Freeport, Mr. O’Connor worked on the due diligence and discovery of a major gold fraud on the Busang gold “deposit” in Kalimantan by Bre-X.

Mr. Mark J. Pryor is a geologist with a 40-year track record of successfully advancing multiple precious metal, copper, coal, REE and Li projects from discovery through to exploitation. He is currently Executive Vice President of the Exploration Division at The Electrum Group.

Aston Bay Holdings Ltd. (OTCQB: ATBHF), closed Friday's trading session at $0.05025, off by 0.297619%, on 1,000 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0412/$0.1164.

Recent News

Energy and Water Development Corp. (OTCQB: EAWD)

The QualityStocks Daily Newsletter would like to spotlightFathom Energy and Water Development Corp. (OTCQB: EAWD) .

The European Commission (EC) has launched a second hydrogen auction to boost clean energy projects and help build the world's renewable energy capacity. The $1.26 billion hydrogen auction had a notably expanded budget compared to the first hydrogen auction and was launched under the European Hydrogen Bank. This second auction is meant to boost the production of Renewable Fuel of Non-Biological Origin (RFNBO) in the European Economic Area (EEA). Renewable hydrogen is expected to play a major role in the European Union's transition to clean energy alongside solar, wind, hydropower, and geothermal energy. The second hydrogen auction was part of the Innovation Fund (IF24) and is integral to the European Union's wider plan to increase its renewable hydrogen production and help meet its energy transition goals. The IF24 Auction's goals align with the Renewable Energy Directive, the Green Deal Industrial Plan, and the REPowerEU Plan and aim to help the regional bloc make its industries more competitive while simultaneously championing green energy use. Provided by national contributors as well as the European Hydrogen Bank, the funding for the second hydrogen auction is set to reach around $2.1 billion, more than enough to speed up renewable hydrogen adoption and help the EU decarbonize its economy. As more regional blocs like the EU undertake practical steps to boost the penetration of clean energy, for-profit enterprises like Energy and Water Development Corp. (OTCQB: EAWD) within this industry could see themselves entering partnerships with governments to support the energy transition.

Energy and Water Development Corp. (OTCQB: EAWD) is a green-tech engineering solutions company focused on delivering water and energy to extreme environments. The company builds water and energy systems out of already existing, proven technologies, utilizing its patent-pending systems configuration and technical know-how to customize solutions to meet clients’ needs. To date, two water systems have been sold and deployed in Mexico and Germany, and the company is working to fulfill additional orders.

Using its patent-pending design, EAWD is working to build and operate off-grid EV charging stations in Germany. The company is a United Nations-accredited vendor and offers design, construction, maintenance and specialty consulting services to private companies, government entities and non-government organizations for the sustainable supply of energy and water.

EAWD focuses on three main aspects of the water and energy business: (1) generation, (2) supply and (3) maintenance. The green tech industry is constantly evolving due to ongoing and increasing water scarcity, as well as increased energy needs in the world. Therefore, the company believes that by designing sustainable and renewable solutions to these problems, EAWD will become an essential component of a rapidly growing industry with many new markets.

EAWD’s approach seeks to assist businesses with the growth and development of their general operations by ensuring the efficient, profitable and sustainable supply and generation of water and energy, allowing its potential customers to focus on their business while adopting strategies of sustainability.

By using the state-of-the-art technological solutions and technologies identified, designed and provided by EAWD and its collaborators, the company believes that its potential clients will be free to focus on the performance of their operations, as well as with the water and energy consumption or generation regulations within their industries.

EAWD is headquartered in Saint Petersburg, Florida, with operations in Germany and Mexico.

Products

In view of the increased worldwide demand for water and energy, EAWD’s business goals are focused on self-sufficient energy-supplied water generation and green energy production. To accomplish this, the company set out to establish an outsourcing green tech platform to commercialize its state-of-the-art technologies while providing engineering and technical consultation services to design the most sustainable technological solutions that can provide water and energy.

The company has sought potential collaboration with green tech research and development centers in Europe and has established its operating subsidiaries in Hamburg, Germany, where EAWD has started to assemble its patent-pending innovative off-grid, self-sufficient energy supply atmosphere water generation (AWG) systems.

EAWD Deutschland and EAWD Logistik operate in Hamburg, Germany, to meet the increasing demands of water and energy generation projects around the world, as well as to operate the solar-powered EAWD Off-Grid EV Charging Stations, EAWD’s newest product.

The company expects to offer sustainable added value to each project it takes on, while generating revenue from the sale of EAWD Off-Grid AWG Systems, EAWD Off-Grid EV Charging Stations, EAWD Off-Grid Power Systems and EAWD Off-Grid Water Purification Systems; royalties from the commercialization of energy and water in certain cases; and licensing of its innovated technologies, along with its engineering, technical consulting and project management services.

EAWD continues to be a development stage company. It presently assembles its EAWD Off-Grid AWG Systems and EAWD Off-Grid EV Charging Stations at its workshop in Germany and outsources most of its engineering and technical services, as well as services relating to the promotion, sale and distribution of its products.

Market Opportunity

According to a report by Allied Market Research, a global market research, consulting and advisory firm, the worldwide green technology and sustainability market was valued at $10.32 billion in 2020 and is projected to reach a value of $74.64 billion by 2030, growing at a CAGR of 21.9% during the forecast period.

A surge in environmental awareness and increasing concerns among organizations and individuals about climate change drive the growth of the market. Furthermore, an increase in consumer and industrial interest for the use of clean energy resources are among some of the major factors expected to boost growth of the market in the coming years, according to the report.

The expected rise in favorable government and private initiatives to tackle climate change and air pollution represent an opportunistic factor of the market. An increase in energy consumption and rise in greenhouse gas emissions are major factors that drive the development of green technology innovations, the report states.

Management Team

Irma Velazquez is CEO and Vice Chair at EAWD. She brings certified expertise in sustainable development and large-scale project management to the company. She formerly worked for United Nations agencies including the World Health Organization, Farmaciens Sans Frontieres, Red Cross and Crescent Societies, where she served in the positions of Information Technology Manager, Sustainable Development Manager, Programme Manager and Disaster and Crisis Management Coordinator. She has a master’s in sciences from the Erasmus University of Rotterdam. She speaks French, English and Spanish.

Ralph Hofmeier is Chief Technology Officer and Chairman at EAWD. He brings a mechanical engineering background to the company and previously served as President of Powermax Energy & Business Solutions Inc. When that company merged with EAWD, he served as President and CEO of Directors of EAWD. Over the last 20 years, he has established and developed several multinational companies in green tech distribution and commercialization. He speaks German and English.

Energy and Water Development Corp. (OTCQB: EAWD), closed Friday's trading session at $0.0015, off by 5.9561%, on 1,855,250 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0012/$0.12.

Recent News

Thumzup Media Corp. (NASDAQ: TZUP)

The QualityStocks Daily Newsletter would like to spotlight Thumzup Media Corp.(NASDAQ: TZUP).

Thumzup Media Corp. (NASDAQ: TZUP) is at the forefront of modernizing the social media branding and marketing industry with its unique platform designed to connect advertisers directly with everyday social media users. The company’s mission is to empower individuals by turning their authentic social media activity into a monetizable asset while providing brands with cost-effective and impactful advertising solutions.

Through its flagship Thumzup platform, the company offers a seamless system where users post about participating advertisers and receive cash payments via Venmo or PayPal. Thumzup recently announced plans to integrate bitcoin as an additional payment option, expanding accessibility for gig economy workers.

By prioritizing accessibility and transparency, Thumzup is redefining traditional marketing strategies with an inclusive, user-driven approach. It is leveraging its scalable technology to disrupt the status quo, offering a win-win ecosystem for advertisers and users alike.

The company is headquartered in Los Angeles, California.

Products

Thumzup’s key offering, the Thumzup platform, features two integrated components: a sophisticated advertiser dashboard and an intuitive consumer-facing app. The advertiser dashboard provides companies with tools to design, manage, and analyze campaigns.

On the consumer side, the Thumzup app allows users to participate in campaigns by posting approved content to their social media accounts. In exchange, users receive direct cash rewards.

Recent enhancements to the platform include the launch of video capabilities, enabling integration with Instagram Reels. This update allows advertisers to tap into the growing popularity of short-form video content, broadening campaign possibilities.

The platform not only incentivizes users but also delivers authentic, relatable content for advertisers, bridging the gap between grassroots engagement and effective campaign management.

Market Opportunity

The global social media advertising market is projected to reach $219.8 billion in 2024, with an expected annual growth rate of 3.86%, resulting in a market volume of $255.8 billion by 2028, according to Statista. Thumzup targets the intersection of this growth with the rise of micro-influencers and everyday social media users, a segment that remains largely untapped in the advertising ecosystem.

In October 2024, Thumzup achieved 202% year-over-year growth in advertisers on its proprietary platform, demonstrating significant traction and scalability. With plans for further expansion in both advertiser partnerships and user engagement, the company is well-positioned to capitalize on the growing demand for authentic and trust-building marketing strategies. As Thumzup integrates innovative features like video support and continues its geographic expansion, it is poised to capture a larger share of the rapidly growing social media advertising market.

Leadership Team

Robert Steele, Founder and Chief Executive Officer of Thumzup, has over 25 years of experience as a technologist and entrepreneur. He has successfully launched multiple companies, including iBrite, a pioneer in mobile software development. Mr. Steele’s leadership and innovative vision drive Thumzup’s mission to democratize the social media marketing industry.

Robert Haag, Director of Thumzup, is the Managing Member of Westside Strategic Partners LLC and a Managing Director at IRTH Communications. With decades of experience in financial communications, investment, and corporate strategy, Mr. Haag provides critical guidance on strategic initiatives and business growth.

Dr. Joanna Massey, member of the company’s Board of Advisors, brings over 25 years of executive experience with Fortune 500 companies and startups to Thumzup. She has held senior roles in communications at Lions Gate Entertainment and CBS Corporation. Dr. Massey leverages her expertise to support Thumzup’s growth strategy.

Thumzup Media Corp. (NASDAQ: TZUP), closed Friday's trading session at $4.91, up 8.8692%, on 221,641 volume. The average volume for the last 3 months is 221,641 and the stock's 52-week low/high is $2.76/$7.89.

Recent News

Annovis Bio Inc. (NYSE: ANVS)

The QualityStocks Daily Newsletter would like to spotlight Annovis Bio Inc. (NYSE: ANVS).

Annovis Bio Inc. Overview

Annovis Bio Inc. (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as AD and PD. Annovis Bio stands out by developing a drug that targets multiple neurotoxic proteins simultaneously, aiming to restore axonal and synaptic activity. This innovative approach addresses both the cognitive decline in AD and the motor dysfunction in PD, making Annovis a unique player in the neurodegeneration space.

Lead Drug Candidate: Buntanetap

Buntanetap (formerly known as Posiphen) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein, and TDP43. This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and protects nerve cells from dying. Unlike monoclonal antibody therapies, buntanetap is an orally available small molecule capable of inhibiting multiple neurotoxic proteins at once, positioning it as a comprehensive solution for neurodegenerative diseases.

In a recent Phase II/III Alzheimer’s study, buntanetap demonstrated statistically significant efficacy. Patients with early AD showed a significantly higher rate of improvement in ADAS-Cog 11 scores across all treatment doses compared to placebo, with a 3.3 point improvement compared to 0.3 for placebo (p < 0.01). Plasma Tau protein levels also reduced, consistent with previous Phase II biomarker data, further validating buntanetap’s mechanism of action.

Similarly, in the recently completed Phase III study of buntanetap in patients with early PD, buntanetap significantly improved disease-related daily non-motor and motor functions in Parkinson’s patients who had a diagnosis over 3 years as well as improved cognition in all PD patients. It further underscores buntanetap’s potential as a transformative therapy.

Market Opportunity

The aging population presents a significant market opportunity, with nearly 7 million Americans currently suffering from Alzheimer’s Disease (AD), a figure projected to rise to almost 13 million by 2050​ (Alzheimer’s Association)​​ (Republican Policy Committee)​. Additionally, approximately 1.2 million people in the U.S. have Parkinson’s Disease​ (SingleCare)​.

The economic burden of Alzheimer’s is immense, with care costs expected to reach $360 billion in 2024 and escalate to nearly $1 trillion annually by 2050​​. The need for effective, comprehensive treatments like Buntanetap is more critical than ever.

Company Highlights

  • Innovative Therapeutic Approach: Annovis Bio uniquely targets multiple neurotoxic proteins, aiming to restore nerve cell health and improve cognitive and motor function in AD and PD patients.
  • Robust Clinical Data: Phase II/III studies show significant improvements in cognitive function and biomarker levels in early AD patients.
  • Groundbreaking Clinical Insights: Recent Phase III data in Parkinson’s Disease patients demonstrates significant improvements in motor and cognitive functions.
  • Upcoming Phase III Trials: Plans are underway for an 18-month Phase III trial focusing on biomarker-positive early AD patients, designed to further validate buntanetap’s disease-modifying potential.
  • Capital Efficiency: Annovis Bio is capital-efficient, with zero debt and multiple global patents extending into the 2040s.

Management Team

  • Maria L. Maccecchini, Ph.D. – Founder, President, CEO, and Executive Board Member, founded Annovis Bio in May 2008 with the mission to develop better therapeutics for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. She has previously been a partner and director at two angel groups, Robin Hood Ventures and MidAtlantic Angel Group, and founded Symphony Pharmaceuticals/Annovis, which was sold to Transgenomic in 2001. Her extensive experience includes roles such as General Manager at Bachem Bioscience and Head of Molecular Biology at Mallinckrodt. Dr. Maccecchini holds a Ph.D. in biochemistry from the Biocenter of Basel, with postdoctoral work at Caltech and the Roche Institute of Immunology.
  • Cheng Fang, Ph.D. – Senior VP of Research and Development, is an accomplished neuroscientist with two decades of experience in neurodegenerative diseases. She has a successful track record of scientific publications and contributions, coupled with extensive pre-clinical and clinical development experience. Dr. Fang has been instrumental in advancing the understanding of neurodegenerative disease mechanisms and developing therapeutic strategies.
  • Michael Christie, Ph.D. – VP of Process Chemistry, has over 40 years of experience in the pharmaceutical industry, focusing on process chemistry R&D, pilot plant production, and GMP operations. He has held senior management positions at companies such as SmithKline, Rhodia, Teva, and Cephalon, and founded a contract process R&D service company, which was later acquired by ChiRex. Dr. Christie is co-author or co-inventor on several publications and patents. He earned his BS in chemistry from the University of Michigan and his doctorate from MIT.
  • Melissa Gaines – Senior VP of Clinical Operations, is an accomplished clinical research professional with over 20 years of experience across academia, contract research organizations, and pharmaceutical companies. She has proven abilities in monitoring and managing Phase I to IV clinical trials, specializing in CNS disorders and extending to a broad range of therapeutic indications. Her CNS experience spans from small Phase I and II studies to large global Phase III trials in Alzheimer’s disease, Parkinson’s disease, sleep disorders, and various psychiatric diseases in both adult and pediatric populations. In her current role, she oversees and supports all clinical project activities, driving operational success and ensuring high-quality clinical outcomes.
Recent Achievements

Annovis Bio continues to advance its mission of developing transformative therapies for neurodegenerative disorders. The company recently announced statistically significant data from its Phase II/III Alzheimer’s study, demonstrating the potential of its lead drug candidate, buntanetap, to improve cognition in patients with early Alzheimer’s Disease (AD). Additionally, the company has released promising data from its Phase III study of buntanetap in patients with early Parkinson’s Disease (PD), which highlights significant advancements in both cognitive and motor functions. These milestones underscore the expanding therapeutic reach of buntanetap.

Investment Considerations
  • Unique Market Position: Annovis Bio is uniquely positioned as the only company developing a drug for both AD and PD that inhibits multiple neurotoxic proteins simultaneously.
  • Strong Clinical Results: Buntanetap’s Phase II/III data shows significant cognitive improvement in early AD patients, and the recent Phase III data in PD patients further validates its broad therapeutic potential.
  • Strategic Growth Plans: With recent successful trial results, Annovis Bio is poised for future growth, supported by strong patent protections and upcoming clinical trials.
  • Significant Market Need: As the prevalence of neurodegenerative diseases continues to rise, the demand for effective treatments like buntanetap remains critical.

Annovis Bio continues to advance its mission of developing transformative therapies for neurodegenerative disorders. The company recently announced statistically significant data from its Phase II/III Alzheimer’s study, demonstrating the potential of its lead drug candidate, buntanetap, to improve cognition in patients with early Alzheimer’s Disease (AD). Additionally, the company has released promising data from its Phase III study of buntanetap in patients with early Parkinson’s Disease (PD), which highlights significant advancements in both cognitive and motor functions. These milestones underscore the expanding therapeutic reach of buntanetap.

Annovis Bio Inc. (NYSE: ANVS), closed Friday's trading session at $6, up 3.0928%, on 259,707 volume. The average volume for the last 3 months is 259,707 and the stock's 52-week low/high is $4.53/$22.49.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Friday's trading session at $5.06, up 34.2175%, on 85,840,760 volume. The average volume for the last 3 months is 85,840,760 and the stock's 52-week low/high is $0.6813/$5.22.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.